ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001074.1|Cosmomycin_1 # 55 # 855 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.720	BGC0001074.1|Cosmomycin_1 	55	855	+	Loose	1020	27.7202	tlrC	38.3	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGGGCCGGCTCGGCTTCGGGGCGCTCCGGCTCACCGGACCCCACCACTGGGGTCCGCCCACCCGGCCGGACAAGGCCGCCGAGGTGGCGCGGTGCGCGGTCGAACTCGGCGTAACGTTCATCGACACCGCCGACGTCTACGGACTCGGGGCCAACGAGGAACTGCTCGCCACGGCGCTCCACCCCTACCCGCCGGGCCTGGTCGTCTCCACCAAGGCGGGCGAGGTCCGGCCGAGCCCGCACCAGTGGCGGGTGCTCGGCCGGCCCGACTACCTGCGCCAGCAGGCCGAACTGAGCCTGCGCCGGCTGCGGCTGGAGCGGATCGAGCTCTTCCAGCTGCACCGGGTCGACCCCCAGGTGCCACTGGAGGACCAGGTCGGAGCACTCAAACAGCTCCAGGACGAGGGCAAGATCCGCCACATCGGGCTCTCCGAGGTGACGGTCGAGCAGATCGAGCAGGCCCGCGGTGTGGCCCGCATCGCGAGCGTGCAGAACAAGTACAACCTCTACGACCGGCGCTACGAGAAGGAGTTGGCGCACTGCGAGCGGGAAGGCATCGCCTTCATCGCCTGGAAGCCGCTCGCCGGTACCGCGAGGCCGGCCCCGGACAGTGCCCTCGCCCGGGTGGCGGCGCAGACGGGGGCGACGACGACGCAGGTGGCGCTCGCCTGGCTGCTGCACCGCTCGCCGGTCGTGATGCCGATCCCGGGCACGGCGTCCCTGTCCCATCTGCGGGCGAACATGGCCGCGGCGGACATCGCCCTCGACGACGAGCAGGTGACCCTGCTCGACGAGGGGTGA	MGRLGFGALRLTGPHHWGPPTRPDKAAEVARCAVELGVTFIDTADVYGLGANEELLATALHPYPPGLVVSTKAGEVRPSPHQWRVLGRPDYLRQQAELSLRRLRLERIELFQLHRVDPQVPLEDQVGALKQLQDEGKIRHIGLSEVTVEQIEQARGVARIASVQNKYNLYDRRYEKELAHCEREGIAFIAWKPLAGTARPAPDSALARVAAQTGATTTQVALAWLLHRSPVVMPIPGTASLSHLRANMAAADIALDDEQVTLLDEG	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	48.54	gnl|BL_ORD_ID|1841|hsp_num:0	1997			1128	1269	lincomycin; tylosin; mycinamicin
BGC0001074.1|Cosmomycin_2 # 918 # 1793 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAGGA;rbs_spacer=4bp;gc_cont=0.652	BGC0001074.1|Cosmomycin_2 	918	1793	-	Loose	200	26.9498	FosX	40.0	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	GTGAAAGGAATTGTCCTGGCGGGCGGCTATGGAAGCCGTTTACACCCGATCACCCTGGCTGTTTCGAAGCAGTTGCTCCCCGTCAACGACAAGCCGCTGATCTACTACCCACTCTCGGCCCTGATGCTGGCCGACGTCCGGGACATCCTCATCATCGCCCTGCCCGGCGACATCCCCCAGCTGCGCAGGCTGCTCGGGGACGGCAGCCACCTGGGGATCTCCCTGACCTACGCCGAACAGCCCGTGCCCAACGGACTGGCACAGGCCTTCCTCACCGGGGCCGAGCACATCGGCGACGACTCGGTCGCCCTCGTCCTCGGTGACAACATCTTTCACGGAAACGGTTTCTACGACCTGCTCGCGGCGCACTCCCGGGACATCGACGGGTGTGTCCTCTTCGGATATCCGGTCACCGATCCCGAGCGCTACGGCGTGGGCGAGGTGGACGAAACAGGCCGGCTCCTCTCCCTGGAGGAGAAGCCCGAGAAACCTAGGTCGAATCTCGCCATCACCGGGCTTTACCTCTACGACAACGACGTCGTGGAGATCGCTCGCCGAATACGCCCGTCAGCCCGCGGCGAACTGGAAATCACCGACGTCAACCGGATCTACCTGGAACAGGACCGGGCCAAACTCGTCACATTCGGCCGCGGATTCGCCTGGCTCGACGCCGGCACCCCGCAGTCGTTGCTCCAGGCCGGCCAGTACGTGCAGACCCTGGAGGACCGGCAGGGCGTACGGATCGCCTGCCTGGAGGAGGTCGCCCTGCGCATGGGCTTCATCGACGCCGACGCCTGCCATCGGCTCGGGGCGAAACTCTCGCGCTCCGGGTACGGCGAGTACGTCATGGCCGTGGCGAACGAGATGAGCGCCTGA	MKGIVLAGGYGSRLHPITLAVSKQLLPVNDKPLIYYPLSALMLADVRDILIIALPGDIPQLRRLLGDGSHLGISLTYAEQPVPNGLAQAFLTGAEHIGDDSVALVLGDNIFHGNGFYDLLAAHSRDIDGCVLFGYPVTDPERYGVGEVDETGRLLSLEEKPEKPRSNLAITGLYLYDNDVVEIARRIRPSARGELEITDVNRIYLEQDRAKLVTFGRGFAWLDAGTPQSLLQAGQYVQTLEDRQGVRIACLEEVALRMGFIDADACHRLGAKLSRSGYGEYVMAVANEMSA	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	218.80	gnl|BL_ORD_ID|111|hsp_num:0	129			234	339	fosfomycin
BGC0001074.1|Cosmomycin_4 # 2604 # 3374 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.689	BGC0001074.1|Cosmomycin_4 	2604	3374	+	Loose	1900	25.7942	MuxC	29.49	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGAAGCGTTCTGGCCACACTGCTGGTACACGCCGACCAGGTGGTACCGGTGTCGTCACTGATACGCGAACTGTGGGACGAGGAGCCTCCGGTCAGCTGCCTGACCACGCTGCAGACCTACATCCTCAACCTGCGCAAGCTGCTGGCGTCCGCGACGGGAATGACCGCCCGTCAGGTCGCCGCGGAGATTCTCGTGACCCGGTCCGGGGGGTACCTGTTCCGGACCACCCAGGGGGACCTGGACGTCCACCGGTTCCACCAGCTCGTCGCGGACGGACGCAGGGCGCTGTCGTCGGGGGACGACCACGCCGCGCTGTCCACGCTCTCCAGCGCGCTGCAACTGTGGCGCGGACCCGCCCTCGTCGACGTCGTCGCCGGGCGGATCCTCGAAGGGCGCCGCCAGCAGTTCGAGGAGTCCCGGCTCGTCGTCCTCGAGTACCTCGTCGACACCCAGCTCCGGCTCGGCATGTACCGGGAGGTGCTCACCGAGCTCGCGGCGCTGACGGCCGACAACCCGTACCACGAGGGGTTGCACGCCCAGTACATGCGGGCGCTGTACCTCAACGGCCGGCGGGCGCAGGCCCTGGAGCTCTTCCAGCGCCTGCGCGTCAACCTGGTGAACCACCTCGGTCTGGAACCCGGACCGATGGCCCAGGAACTCCATCGCTCCATCCTCAACGCGGAGTCGATCGACGCCCAGGGCAACCTCCGCAGGCCGACCGGGGACATCGTGCGCATGTCGTCCTCCGGCGCGGTGCGGGTCTACTGA	MRSVLATLLVHADQVVPVSSLIRELWDEEPPVSCLTTLQTYILNLRKLLASATGMTARQVAAEILVTRSGGYLFRTTQGDLDVHRFHQLVADGRRALSSGDDHAALSTLSSALQLWRGPALVDVVAGRILEGRRQQFEESRLVVLEYLVDTQLRLGMYREVLTELAALTADNPYHEGLHAQYMRALYLNGRRAQALELFQRLRVNLVNHLGLEPGPMAQELHRSILNAESIDAQGNLRRPTGDIVRMSSSGAVRVY	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	24.71	gnl|BL_ORD_ID|2367|hsp_num:0	2720			1173	1389	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0001074.1|Cosmomycin_5 # 3461 # 4318 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=3bp;gc_cont=0.704	BGC0001074.1|Cosmomycin_5 	3461	4318	-	Loose	400	36.1946	Erm(34)	26.03	3000600	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACAAGACGATGTACAAATCGACGGTCACCGAGGCGTTCAACAATGCCGCGGCGACGTATGACCAGTTGGGCGTCGAGTTCTTCACACCGATGGGCCGGCGACTTGTGGAAAGGGCCGATCCGCAGCCCGGGCAACGCGTTCTCGACGTCGGGTGCGGGCGGGGCGCGTCCCTGTTCGTGGCGGCGGAACGGGTGGGTCCTTCCGGCCATGTGCTCGGCATCGACATCGCGCCCGCGATGGTGGAGGAGGCCCGGCGGCAGGCCGGCGCGCTCGGCGCCCGGCACGTCGAGGTCCGGGTCATGGACGGCGAGCACCCCGACCTTCCGCCCGCCTCGTTCGACGTGGTGACCGGCAGCTACAGCCTGATCTTCCTGCCCGACGCTCCGGCCGCGCTCCCCCGGTACGCGGCCCTGCTGCGGCCGGGTGGCCGGATCGCCTTCACCAGCCCGGTCTTCACGGAGGACACGTTCCCCTTCCTGCCGCCCGTGTTCACGGACCTCATCCCGGAGCGGCTGCTGCGCAACCTGCCGGCGGACTGGCGCCCGGACGCGCTGAAGCGGCGGTTCAACAGCTGGCTGCAGGACACCGACGACCTGACCCGGACGATGGTGCGCGCCGGGTTCGACGACGTGGAGATCGCCGACGAGCACATCGATCTGCGCGCGCCGGACGGGGAGACCTGGGTCGACTGGTCCCACACCCAGGGAATGCGGTTGCTGTGGCAGCACCTCCCGGAGTACGAGAACCGGCAGCTGCGCCACCGCCTGACCACGGAACTGGACCGGCTGCGCGGCGACGGCCCCCTTCATCTGCCCACACCGGTCCGGTTCGTCCACGCCTCGATCGCGGGCTGA	MDKTMYKSTVTEAFNNAAATYDQLGVEFFTPMGRRLVERADPQPGQRVLDVGCGRGASLFVAAERVGPSGHVLGIDIAPAMVEEARRQAGALGARHVEVRVMDGEHPDLPPASFDVVTGSYSLIFLPDAPAALPRYAALLRPGGRIAFTSPVFTEDTFPFLPPVFTDLIPERLLRNLPADWRPDALKRRFNSWLQDTDDLTRTMVRAGFDDVEIADEHIDLRAPDGETWVDWSHTQGMRLLWQHLPEYENRQLRHRLTTELDRLRGDGPLHLPTPVRFVHASIAG	MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTTILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSITTAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSFSPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKVRQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR	101.42	gnl|BL_ORD_ID|7|hsp_num:0	11			99	519	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001074.1|Cosmomycin_6 # 4506 # 4943 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.658	BGC0001074.1|Cosmomycin_6 	4506	4943	+	Loose	290	26.1794	golS	35.85	3000504	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGTGACCACATCGACATTGTGCGCCGCATGGTGAACAGCTACAACACCGGAAAAACGGATGACGTCGCCGAGTTCATTCACGAGGAGTACCTCAATCCCGGTGCCCTGGAGCACATGCCGGAACTGCGCGGCCCCGAGGCGTTCGCACTCGCGGTGAAGTGGCTGAAGCTCACGTTCTCCGAGGACGCGTACCTGGAGGAGATCGGTTACGAGGAGAAAGGCAGCTGGGTGCGGGCGAAACTCGCCCTGTACGGCCGCCAGGTGGGCGAACTCGTGGGGATGCCCGCCACCGGACGCCGCTTCTCCGGGGAGCAGATCCACCTCATCCGCATCGTCGACGGCAAGATCCGCGACCACCGCGACTGGCCGGACTACCTCGGCACCTACCGCCAGCTCGGCGAGCCCTGGCCCACGGAGGAGGGCTGGCGGCCCTGA	MSDHIDIVRRMVNSYNTGKTDDVAEFIHEEYLNPGALEHMPELRGPEAFALAVKWLKLTFSEDAYLEEIGYEEKGSWVRAKLALYGRQVGELVGMPATGRRFSGEQIHLIRIVDGKIRDHRDWPDYLGTYRQLGEPWPTEEGWRP	MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSVAEISDLLNLWNNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDCPILHTLGQPDDSEPEARTGAVLRRPRRHGLAKRL	94.16	gnl|BL_ORD_ID|35|hsp_num:0	44			3	153	chloramphenicol
BGC0001074.1|Cosmomycin_7 # 4985 # 6088 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.744	BGC0001074.1|Cosmomycin_7 	4985	6088	+	Loose	400	28.1054	vatH	22.0	3002845	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGAGCTCTTCCTCACCCGGCGAACACCCGGAACCGACCGACCAGGACCTCGACGTACTCCTCAAGAACCTCGGCAACCTGGTGACCCCGATGGCCGTCCGGGTCGCCGCGACGCTCCGCCTCGTCGACCACCTGCTGGCCGGGGCCGGTACCGTCGCCGACCTCGCCGCCCGCACGGACACCCACCCCCAGGCACTCGCCCGCCTGGTCCGCCACCTGACCGTGGTCGGCGTCCTGGAGGGCGGGGAGCCGGGCCGGCCCCTGCGGCCCACCCGGCTCGGGCTGCTCCTCGCCGACGGCCATCCGGCGCAGCAGCGGGCCTGGCTGGACCTGAACGGGGCCGTCTCCCACGCCGACCTGGCCTTCACCGGCCTCCTGGACGTGGTGCGCACCGGCCGTCCCGCCTACTCCGGGCGGTACGGGCGGCCCTTCTGGGAGGACCTCTCGGCGGACCGGGCGCTGGCCGACTCGTTCGACGCGCTCATGTCCTGCGACGAGGACCTGGCCTTCGAGGCCCCGGCCGACGCCTACGACTGGTCGGCGGTGCGGCACGTCCTCGACGTGGGCGGCGGCAACGGCGGCCTGCTCGCGGCGATCGCCCTGCGGGCACCGCACGTCCGGGGCACCCTGGTCGAACTGGCGGGCCCGGCCGAGCGCGCCCGGCGCAGGTTCGAGGACGCCGGGGTCGACGACCGGGTCACCGTGGCGGAGGGAGACTTCTTCAAGCCGCTGCCCGTCACCGCCGACCTCGTCCTGCTCTCCTTCGTCCTGCTCAACTGGTCCGACGAGGACGCGCTGACGATCCTGCGGCGCTGCGTCCAGGCCCTCGAACCGGGCGGCAGGATCCTCGTCCTGGACCGTGCCGACGTCGAGGGCGACGGCGCCGACCGGTTCTTCAGCACCCTGCTCGACCTGCGGATGCTGACGTTCATGGGCGGTCGGGTGCGCACCCGGGACGAGGTCGTGGCCCTGGCCGGCTCGGCCGGACTCGCCCTGGCGTCGGAGCGCACCAGCGGCTCCGCCACCCTCCCGTTCGACTTCTCGATCCTCGAGTTCACCGCCGCCCCCGAGGGGGCCGCCCCCGTCCTCCCAGCACAGGAGTAG	MSSSSPGEHPEPTDQDLDVLLKNLGNLVTPMAVRVAATLRLVDHLLAGAGTVADLAARTDTHPQALARLVRHLTVVGVLEGGEPGRPLRPTRLGLLLADGHPAQQRAWLDLNGAVSHADLAFTGLLDVVRTGRPAYSGRYGRPFWEDLSADRALADSFDALMSCDEDLAFEAPADAYDWSAVRHVLDVGGGNGGLLAAIALRAPHVRGTLVELAGPAERARRRFEDAGVDDRVTVAEGDFFKPLPVTADLVLLSFVLLNWSDEDALTILRRCVQALEPGGRILVLDRADVEGDGADRFFSTLLDLRMLTFMGGRVRTRDEVVALAGSAGLALASERTSGSATLPFDFSILEFTAAPEGAAPVLPAQE	MAEKLKGPNSNEMYPIAGNKSVQFVKPSLTRPNIIVGEFTYYDSKNGELFEDQVLYHYEIIGDRLIIGKFCSIGPGVTFIMNGANHRMDGSTYPFNIFGHGWEKHTPTLDMLPLKGDTIVGNDVWIGLDATIMPGVKIGDGAIIAAKSVVTKDVDPSTIVGGNPAKQIKKRFSESKIQELLKIKWWDFEDQVISDNIDAILSLDVEALNNISKEND	169.91	gnl|BL_ORD_ID|774|hsp_num:0	837			414	564	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0001074.1|Cosmomycin_8 # 6093 # 6989 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.730	BGC0001074.1|Cosmomycin_8 	6093	6989	+	Loose	600	131.724	EstT	28.09	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGTCCGAACGCATCGTGCCCAGCGGGGACGTCGAGCTGTGGAGCGACGACTTCGGCGACCCGGCGGACCCGGCGCTGCTGCTCGTCATGGGCGGCAACCTCTCCGCCCTGGGCTGGCCCGACGAGTTCGCCCGGCGGCTCGCCGACGGCGGCCTCCACGTCATCCGCTACGACCACCGCGACACCGGCCGCTCCACCACCCGCGACTTCGCCGAACACCCCTACGGCTTCGGTGAACTGGCCGCCGACGCGGTCGCCGTCCTCGACGGCTGGGGCGTCGACCGCGCCCATGTCGTCGGCCTGTCGATGGGCGCGACCATCGCGCAGGTCATCGCGCTCGACCACCACGACCGGCTGAGCAGCCTGACCATGATGCTGGGCGGCGGGCTCGACATCGACTTCGACGCCAACATCGAGCGCGTGATGCGCGGCGAACCCACGCCGGACGGCCTGCCCGGGCCGCAGCAGCCGTTCCTCGACGCGCTCGCCCTGATGCAGCAGCCGGCCGAGGGGCGCGCCGCCGAAGTGGCCAAGCGGGTGAGCAAATGGCGCATCCTCTCCGGGACCGGTGTGCCGTTCGACGACGCCGAGTACGCGCGGTGGGAGGAAAGGGCGATCGACCACGCGGGCGGTGTCCTCACCGAGCCGTACGCGCACTACTCCCTGACCCTGCCGCCGCCGGAGCGGGCCGCCGAACTGCGCGACGTCACCGTGCCGGCCCTGGTCATCCAGGCCGAGCACGACCCCATCGCACCCGCGCCGCACGGCAAGCACCTGGCCGGACTCATCCCCACCGCCCGTCTGGTGGAGATCCCCGGCATGGGGCACGCCCTGCCGTCCTCGGTCCACGGGCCGGTGGCCGAGGCCATCCTCGCCCACACCCGAGGGGCGTCATGA	MSERIVPSGDVELWSDDFGDPADPALLLVMGGNLSALGWPDEFARRLADGGLHVIRYDHRDTGRSTTRDFAEHPYGFGELAADAVAVLDGWGVDRAHVVGLSMGATIAQVIALDHHDRLSSLTMMLGGGLDIDFDANIERVMRGEPTPDGLPGPQQPFLDALALMQQPAEGRAAEVAKRVSKWRILSGTGVPFDDAEYARWEERAIDHAGGVLTEPYAHYSLTLPPPERAAELRDVTVPALVIQAEHDPIAPAPHGKHLAGLIPTARLVEIPGMGHALPSSVHGPVAEAILAHTRGAS	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	97.39	gnl|BL_ORD_ID|4956|hsp_num:0	5948			72	909	tigecycline
BGC0001074.1|Cosmomycin_9 # 6986 # 7735 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.731	BGC0001074.1|Cosmomycin_9 	6986	7735	+	Loose	400	32.7278	Erm(30)	28.72	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCGTGGCGGACGAACAGCGGGCGGGGGAGACGATGTACGGGGCGGACCTCGCCCGGGTCTACGACCTCGTGCACCGGGAGCGGGGCAAGGACTACCGCGCCGAGACCGAGGCGGTCGCCGCCGCCGCCCGGCAGCGCCGGCCCGGCGCCGGACGGCTGCTCGACATCGCGTGCGGCACCGGCGGCCATCTGCGGCACTTCACCGAGCTGTTCGCGCACGTGGAGGGGGTGGAGCTGTCGGCGCCGATGGCCGAGGCGGCGCGCGCCGCGCTGCCCGGGGTGACCGTGCACCGCGGCGACATGCGCGACTTCCGCCTGGACACCACCTTCGACGTGGTGACCTGCATGTTCGGATCCATCGGCTACATGACGTCGGTGGCCGAACTGGGCCGGGCGCTCACCGTGTTCGCCCGGCACCTGGAGCCCGGCGGGGTGGCCGTCGTCGACCCGTGGTGGTTCTACGAGACGTTCGCCGACGGCCATGTCTCGGCCGACGTCGTGACCGTCGACGGCGTCACCGTCTCCCGGGTCTCGCACTCCGCCCGCCGCGGCCGCACCTCGCACATGGACGTGCACTTCGTGGTCGCCGAACCCGGCGTCGGCGCCCGGCACTTCGTCGACACCCACATCATCTCCCTGTTCAGCCGCGCCGAGTACGAACAGGCGTTCCGCGAGGCCGGCTTCGCGGTCGAGTACCTGCCCGACGCGCCGTCGGGCCGCGGCCTGTTCGTCGGCGTCCGGATGTGA	MTVADEQRAGETMYGADLARVYDLVHRERGKDYRAETEAVAAAARQRRPGAGRLLDIACGTGGHLRHFTELFAHVEGVELSAPMAEAARAALPGVTVHRGDMRDFRLDTTFDVVTCMFGSIGYMTSVAELGRALTVFARHLEPGGVAVVDPWWFYETFADGHVSADVVTVDGVTVSRVSHSARRGRTSHMDVHFVVAEPGVGARHFVDTHIISLFSRAEYEQAFREAGFAVEYLPDAPSGRGLFVGVRM	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	74.11	gnl|BL_ORD_ID|1123|hsp_num:0	1224			39	321	narbomycin; methymycin; pikromycin
BGC0001074.1|Cosmomycin_10 # 7779 # 9374 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=5bp;gc_cont=0.737	BGC0001074.1|Cosmomycin_10 	7779	9374	+	Loose	550	117.087	Nocardia farcinica rox	32.79	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACGACCACGAGGTCGACGTTCTGGTGGTGGGTGCGGGCCTCGGTGGCCTGTCGACGGCGATGTTCCTCGCCCGGCAGGGGGTGCGCGTGCTCGTGGTGGAGCGCAGGTCCGGCCTCTCGCCCTATCCGCGGGCCGCGGGGCAGAACCCGCGCACCATGGAGCTGCTGCGCATCGGGGGCGTCGCCGACGAGGTGACCCGGGCCAACGACATCCGCGGCGCCCAGGGGGACTTCGTCATCCGGCTCGCCCAGAGCGTGCGGGGCGAGATCCTGCGGACCGTCTCGGAGAGCTTCGACGACATGGTGGCCGCGACCCGGCCGTGCACCCCGGCCGGCTGGGCGATGCTGTCCCAGGACAAGCTGGAGCCGATCCTGCTCGCGCAGGCGGAGCGGCACGGCGGCGCCATCCGCTTCGACACCCGGCTGGTGTCGTTCGACCAGGACGCGGACGGTGTCACGGCCCGGCTCCAGGGGCCCGAGGGCAAGTACGACCTGCGCGCCGGCTACCTCGTCGGCGCCGACGGCAACCGCAGCCTGGTCCGGGAGTCGCTGGGGATCGGGCGGTACGGGCACGGCACGCTGACCCACATGGTCGGGGTCATCTTCGACGCGGACCTCTCCGGCATCATGGAGCCGGGCACGACGGGCTGGTACTACCTGCACCACCCCCAGTTCACCGGCACGTTCGGGCCGACGGACCGGCCCGACCGGCACACCCTCTTCGTCGAGTACGACCCCGACGAGGGCGAGCGCCCCGAGGACTTCACGCCGGAGCGCTGCGTCGAGCTGATCGGCCTCGCCCTGGACGCTCCCGAGGTGCGGCCGGAGCTGGTCGACATCCAGGGCTGGGAGATGGCGGCCCGGATCGCCGAACGCTGGCGCGAAGGGCGGGTGTTCCTCGTCGGGGACGCGGCGAAGGTGACGCCGCCGACCGGCGGCATGAGCGGCAACGCGGCCGTCGCCGACGGGTTCGATCTGGCCTGGAAGCTGGCGGCGGTGCTGCACGGGCAGGCCGGGCCGGGACTCCTCGGCACGTACGAGGACGAGCGCAAGGTCGCCGCGGAGCTGGTCGTGGCGGAGGCGCTGGCGATCTACGCGCAGCGGATGGCGCCGCACATGGCGGACGTGTGGGACAAGTCGGTGGGGTACCCCGAGACGCTGCTCGGCTTCCGCTACCGCTCCTCGGCGGTCCTGGCCACGGACGACGACCCGGCGCGGGTGGAGAACCCGATGACCCCGAGCGGCCGCCCCGGCTTCCGGGGACCGCACGTCCCGGTGACCCGGCACGGCGAACGGATCTCCACGGTCGACCTGTTCGGCGACGGCTGGACCCTGCTCGCCGGTGAGCTGGGAGCGGACTGGGTCGCGGCGGCGGAGACGGTCTCGGCGGAACTGGGGGTCCCGGTCCGGGCGTACCGGATCGGTGCCGGCCTCACGGATCCCGAGGCCGCGGTGGCCGACCGGTACGGCATCGGCAAGGCGGGGGCGAGTCTGGTCCGCCCCGACGGCATCGTCGCCTGGCGCACGGACGAACCGCCGTCCGACGCCGCGGACGCCCTCGGCGGAGCCCTGCGCAAGGTCCTCTCCCGCTGA	MNDHEVDVLVVGAGLGGLSTAMFLARQGVRVLVVERRSGLSPYPRAAGQNPRTMELLRIGGVADEVTRANDIRGAQGDFVIRLAQSVRGEILRTVSESFDDMVAATRPCTPAGWAMLSQDKLEPILLAQAERHGGAIRFDTRLVSFDQDADGVTARLQGPEGKYDLRAGYLVGADGNRSLVRESLGIGRYGHGTLTHMVGVIFDADLSGIMEPGTTGWYYLHHPQFTGTFGPTDRPDRHTLFVEYDPDEGERPEDFTPERCVELIGLALDAPEVRPELVDIQGWEMAARIAERWREGRVFLVGDAAKVTPPTGGMSGNAAVADGFDLAWKLAAVLHGQAGPGLLGTYEDERKVAAELVVAEALAIYAQRMAPHMADVWDKSVGYPETLLGFRYRSSAVLATDDDPARVENPMTPSGRPGFRGPHVPVTRHGERISTVDLFGDGWTLLAGELGADWVAAAETVSAELGVPVRAYRIGAGLTDPEAAVADRYGIGKAGASLVRPDGIVAWRTDEPPSDAADALGGALRKVLSR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	112.26	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	993	rifampin
BGC0001074.1|Cosmomycin_11 # 9631 # 10665 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=5bp;gc_cont=0.701	BGC0001074.1|Cosmomycin_11 	9631	10665	-	Loose	200	27.335	vanH gene in vanO cluster	28.87	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGCCAGAGCACCGTCAGCAACGGGCGCTCCGAATGGGCGTGATCGGAACGGCGAACATCGCGATGCGCCGGATCATGCCTGTTCTCGCCGCGCACGACCATGTGGACCTCGTCGCGGTGGCCAGCCGGGACAAGGCGAGGGCCGAGCGGGTGGGAGCCGCGTTCGGCTGCCACGGCGTGGGGGATTACGCGGAGCTCGTCGAGCGGGACGACCTGGACGCCATCTATATTCCGCTGCCACCGGCCATGCATCACGAGTGGGCCCTACGGGCTTTGCGGTCGGGAAAACACGTGCTCGTCGAGAAACCGATGTCGGACACGTACGAGAAGACGCTCGAGCTGATGTCGACCGCGTCGGAACTCGGACTCGTGCTGGCCGAGAACTTCATGTTCCTGCACCATTCCCAGCACGCCGCGGTGCGCGCGATGCTCGACGAGGCCGTGGGGGAACTGCGGCTGTTCTCCGGGTCGTTCGCCGTGCCGCCGCTGGCCCCGGAGTCGTTCCGGTACCAGCCGGCGCTGGGCGGGGGCGCGTTGCTCGACGTCGGGGTGTATCCGCTGCGCGCGGCCCAGCTGTACCTGGCCGGTGAGCTCGAGGTGCTCGGGGCGTGTCTGCGCGTGGACGAGGCGACCGGGGTGGACGTGGCGGGCAGCGTGCTGCTGAGCGACGACCGGGGGGTGACGGCCCAGCTGGACTTCGGCTTCGAACACTCCTACCGGTCGACCTACGCGCTGTGGGGCAACCGGGGGCGGGTGAGCGTCCGGCGGGCCTTCACGCCGCCGGAGCAGTTGAAGCCGGTGGTCCGGATCGAGCAGCAGGACGTGGTGACGGAGCGGTCGCTGCCCGAGGACAACCAGGTGTTCAACGCGATGGACGCGTTCGTCCGCGCGGCCCTCACGGGCACGGGCCCCCTCACCGACACGTCCGTGATCCACCGCCAGGCCCTCCTGGTCGACCGCGTCCGCCGCGCGGCGACGCTCGTCGGCGACCCGAAGACCCGCCCGAGCGACGTCCTGGCGGAGGATCTGGCCTGA	MPEHRQQRALRMGVIGTANIAMRRIMPVLAAHDHVDLVAVASRDKARAERVGAAFGCHGVGDYAELVERDDLDAIYIPLPPAMHHEWALRALRSGKHVLVEKPMSDTYEKTLELMSTASELGLVLAENFMFLHHSQHAAVRAMLDEAVGELRLFSGSFAVPPLAPESFRYQPALGGGALLDVGVYPLRAAQLYLAGELEVLGACLRVDEATGVDVAGSVLLSDDRGVTAQLDFGFEHSYRSTYALWGNRGRVSVRRAFTPPEQLKPVVRIEQQDVVTERSLPEDNQVFNAMDAFVRAALTGTGPLTDTSVIHRQALLVDRVRRAATLVGDPKTRPSDVLAEDLA	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	98.29	gnl|BL_ORD_ID|761|hsp_num:0	786			510	753	vancomycin
BGC0001074.1|Cosmomycin_12 # 10828 # 11967 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.789	BGC0001074.1|Cosmomycin_12 	10828	11967	+	Loose	800	30.0314	cmlB1	35.06	3002699	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACGGCGGCGACGAATGCCCTGGGGCGCGAACTACAACTCGTCCACGCGGCGCAATGGCTCTACGCGATCAACGGCGAGCCGTTCGTGCCGGGGGAGGGCGACCCGTACGCGCGGCTGGTACGGGGATTCGACAGCGGCGAGGACCGCGCGGACGACGCGGGCGGGCTCCTCGCGTCGGTCGCGGAGCGAGGGCCGGTGTGGCGCAGCCGGCTCGACACCTGGGTCGTCACCGGCCCCAGGGCGCTCCGGGAACTGTCCGGCAGCCGGGACCTGGCGGTGTCCGCCGCCGTTCCGCAGGCGGAGGCGTGGCTGCCCGACCCGGCGCGCCAGCGCACCACGGCGCTCGTCCGGGACCTGGCACTGCGGGGCGGCACGAGGGCCGTGCGCGGGCACGCCGGAGCGCTGCGGGAACAGGCCACGCGGGCGGCGGCCCGGCTCGGGCCGGGCCCCGTCGACCTGATGGCCGACTTCGCCGAGCCGCTGACCGCGGTGGCGTACGCCGTCCTCCTGGACGTGCCCGAGGAGCGGCACGCGGCGTTCGCCGCCGGCCTCGCCGGGACCGCACCGGCCGTGGACGCGCTGCTCTGCCCGCAGACGCTGGAGGTGACGCGGCGCCTGGCTGCAGGCGTGCGAGGACTGCGGGAGCTGTTCGCCGGGCGGGACCGGGCGGAGGCGGACCTGCTGCTCGCCGTGGCCGGGGCCCGGGCCGCGGCGGACCTGCTCGGCAACGCCCTGCACATGCTCCTCGACCGGCCGCACGACTGGGCGCTGCTGCGCTCGGACCCTGCGCACGCGGCCCGGCTGGTCGAGGAGGCCCTGCGCGGCCGGCCGCTGTGGCGGGCTCTCCCCCTGGTGGCCCTCGCCCCGGCCGAGGTGGCCGGCGCCCGCATCGAGACCGGCGACACCGTCACCGTCGTGACCACCGGGACCGGCGCCGGCCCGGCCCCGCTGCCCGTGCCCGCCTGCGCCGCCCTGCTCCCGGCCGCGACCGCGCTGGCCGAGCAGGCGCTGGCGGCACTGGGCGCGCGGTTCGAGCTGCTGCGGCCGGACGGCGACCCGGTGCGCCTGCGCCGGGCGCCCCTGACCCGGCGCCTGGTCAGGCTGCCGGCCCGACTCGGCGAGGAGGAGACGCGATGA	MTAATNALGRELQLVHAAQWLYAINGEPFVPGEGDPYARLVRGFDSGEDRADDAGGLLASVAERGPVWRSRLDTWVVTGPRALRELSGSRDLAVSAAVPQAEAWLPDPARQRTTALVRDLALRGGTRAVRGHAGALREQATRAAARLGPGPVDLMADFAEPLTAVAYAVLLDVPEERHAAFAAGLAGTAPAVDALLCPQTLEVTRRLAAGVRGLRELFAGRDRAEADLLLAVAGARAAADLLGNALHMLLDRPHDWALLRSDPAHAARLVEEALRGRPLWRALPLVALAPAEVAGARIETGDTVTVVTTGTGAGPAPLPVPACAALLPAATALAEQALAALGARFELLRPDGDPVRLRRAPLTRRLVRLPARLGEEETR	MRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLVLLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACLVSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMIGAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLMMGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGETLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGTFIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLATQDIGRSQSGHGHD	90.02	gnl|BL_ORD_ID|954|hsp_num:0	1038			378	594	chloramphenicol
BGC0001074.1|Cosmomycin_13 # 11964 # 13283 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=8bp;gc_cont=0.722	BGC0001074.1|Cosmomycin_13 	11964	13283	+	Loose	700	49.6766	oleI	24.57	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAAGGTTCTGTTCACCTCACTGGCCCACCACACCCACTACTACCCACTCGTGCCGCTGGCGTGGGCGCTGCGCACCGCGGGCCACGAGGTGCGGATCGCCAGCCAGCCCGAGCTGACCGACGTCATCACGGGCACGGGACTGACCGCCGTCCCCGTCGAGTGGTCGCTCGGCGCCCTGGAGGACCTCGGCCTGCTCGGCAAGCTCCACGACGAGGCCTCGGCCCACGTGCAGGGCTTCGACTACGCCGCCCGGGGCGAACACCCCTGGACGTACGAGCAGTTGCTCGCGCTGGAGAACGTGATGGTGCCGACGCTGTACGGCGCCCTCAACAACGACACCATGGTCGACGCCCTGGTGGACTTCGCCCGCTCCTGGCAGCCCGACCTCGTCGTCTGGGAGACCTTCACCCTCACCGGGGCCATCGCGGCGCGGGTGACGGGAGCGGCCCACTGCCGGCTGGTCTCCGGCCCCGACATCAGCGTGCGGGCCCGCAAGGAGTTCCTGCGGCTGGCCGCCGAGCAGGAGCCGGAGCACCGCGAGGACCCCACCGCCGAGTGGCTGGAGCGCACCCTGCGGCGGCTGGGCTGCGCGGCCGGCTTCGACGAGGACATGGTCACCGGCCAGTGGACCGTCAACACCACGCCGCCCAGCACCCAGCTCGACCTGGACCTGCCGACCGTCCAGGTGCGGCACGTGCCGTACAACGGTCCCGCGGTCGTGCCGGAGTGGCTGCGGAGCCACCCCGGGCGCAGCCGCGTCTGCGTGACGCTCGGCTCCTCGGCCTCCGACGTCGGCGTCGACATGGCCGAACTGCTCGCGCACCTCGCGGAGCTGGACGCGGAGATCGTCGCCACCGTCGACGAGGCGACCCGCGAAGCGGCGAAGGACCTGCCGGACAACGTACGCCTCGTCGACTTCGTCCCGCTCAACGACCTGCTGCCCACCTGCGACGCGGTCGTCCACCACGGTGGCGTCGGCACCAAGGCCACGGCCGAACTGCACGCCGTGCCCCAGCTGATCCTGGCCTTCGGCTGGGACACCGAGGTCATGGGCCGCGGGCTGGAGGACATCGGCGCCGGCCTGTGCGTGCCGAGCGACGGCCTGCTGCCCGACGTGCTGCGCAAGCAGGTCCAGCGACTGATCAGCGAGCCGTCGTTCGCCCACGGGGCCCGACGGCTCCAGGAGGAACTGCTCGCCGTGCCCAGCCCCAACGAGGTCGTCCCGGTGCTGGAACGGCTGGTCGCCGAACACCGCGGCGCCCCCGGGGCCGCGACGGCGGAGCACGGCACGAACGGGTTAGGCCACCACCGAGGATGA	MKVLFTSLAHHTHYYPLVPLAWALRTAGHEVRIASQPELTDVITGTGLTAVPVEWSLGALEDLGLLGKLHDEASAHVQGFDYAARGEHPWTYEQLLALENVMVPTLYGALNNDTMVDALVDFARSWQPDLVVWETFTLTGAIAARVTGAAHCRLVSGPDISVRARKEFLRLAAEQEPEHREDPTAEWLERTLRRLGCAAGFDEDMVTGQWTVNTTPPSTQLDLDLPTVQVRHVPYNGPAVVPEWLRSHPGRSRVCVTLGSSASDVGVDMAELLAHLAELDAEIVATVDEATREAAKDLPDNVRLVDFVPLNDLLPTCDAVVHHGGVGTKATAELHAVPQLILAFGWDTEVMGRGLEDIGAGLCVPSDGLLPDVLRKQVQRLISEPSFAHGARRLQEELLAVPSPNEVVPVLERLVAEHRGAPGAATAEHGTNGLGHHRG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	103.54	gnl|BL_ORD_ID|1684|hsp_num:0	1824			741	1266	oleandomycin
BGC0001074.1|Cosmomycin_14 # 13295 # 14596 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.687	BGC0001074.1|Cosmomycin_14 	13295	14596	+	Loose	375	26.5646	fusD	24.53	3003731	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	GTGACGGACACCAAGGCGCTGGTGCTGGAACTGGCGCGCAAGTACCACAAGGAACAGGAAACGCGGGCGTTCGAACCGGGAGTCACGCCGATCCTGTCCTCGGGCGCGGTCCTCGACGAGGAGGACCGGCACGCCTTGGTCGAGGCCGCACTGGAGATGCGGATCGCCGCCGGCGTGCGCACCCGGAAGTTCGAGAGCGAGTTCGCCCGCTACTTCCGGCTGCGCAAGGCGCACATGGTGAACTCGGGATCGTCGGCCAACCTGCTGGCGGTCAGCGCGCTCACCTCGCCGAAGCTGAAGGACCTGCGGCTGCGCCCCGGCGACGAGGCCATCACGGTGGGCGCCGGCTTCCCGACCACGATCAACCCGCTCGTCCAGAACGGCCTGACGCCGGTCTTCGTGGACGTGGAACTGGGCACCTACAACGCCTCGCTGGCGCAGATCGAGGCGGCGATCTCCCCGCGCACCCGGCTCATCATGATCGCCCACGCCCTCGGCAACCCGTTCCCCGTCGCCGAGGTCGCGGAACTCGCCCGCCGGCACGACCTGTTCCTCATCGAGGACAACTGCGACGCCGTCGGCTCCACCTACCAGGGCAAACTCACCGGCACCTTCGGCGACCTGTCGACGGTGAGCTTCTACCCGGCCCACCACATCACCGCGGGCGAGGGCGGCTGCGTCCTGACGGCGAGCCTGGAACTGGCCCGGATCGTGGAGTCGATGCGCGACTGGGGCCGGGACTGCTGGTGCGAACCGGGCACCGACAACACCTGCCTGAAGCGGTTCGACTACCAGCTCGGCACCCTCCCGGCCGGCTACGACCACAAGTACATCTTCTCCCACGTCGGCTACAACCTGAAGGCCACCGACCTCCAGGGCGCCCTGGCCCTCAGCCAGTTGCAGAAGGTCGACGACTTCGTCGCGGCCCGCCGCCGCAACTGGCAGCGGCTGCACGACGGACTGGCCGCAGTGCCCGGACTGCTGCTGCCGCGGGCCACCCCGGGCAGCGACCCCAGCTGGTTCGGCTTCGCCCTGACCGTGCTGCCCGGCGCGGGCTTCACCCGCAGGGACCTCGTCGACTTCCTGGAGGGCCGGAAGATCGGCACCCGACGGCTGTTCGGCGGGAACATCACCCGTCACCCCGCCTACCAGGACGTGCGCTACCGGATCGTGGACGAGCTGACCAACTGCGACACCGTCACCGAGGACACCTTCTGGATCGGCGTCTACCCGGGGCTGACCAGCGAAATGCTCGACTACGTCATCGAGACCATCACCGAGTTCTGCACGCGAAGGGGCTGA	MTDTKALVLELARKYHKEQETRAFEPGVTPILSSGAVLDEEDRHALVEAALEMRIAAGVRTRKFESEFARYFRLRKAHMVNSGSSANLLAVSALTSPKLKDLRLRPGDEAITVGAGFPTTINPLVQNGLTPVFVDVELGTYNASLAQIEAAISPRTRLIMIAHALGNPFPVAEVAELARRHDLFLIEDNCDAVGSTYQGKLTGTFGDLSTVSFYPAHHITAGEGGCVLTASLELARIVESMRDWGRDCWCEPGTDNTCLKRFDYQLGTLPAGYDHKYIFSHVGYNLKATDLQGALALSQLQKVDDFVAARRRNWQRLHDGLAAVPGLLLPRATPGSDPSWFGFALTVLPGAGFTRRDLVDFLEGRKIGTRRLFGGNITRHPAYQDVRYRIVDELTNCDTVTEDTFWIGVYPGLTSEMLDYVIETITEFCTRRG	MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRNTTIRSNVEKLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKSFCSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ	203.29	gnl|BL_ORD_ID|2037|hsp_num:0	2248			33	450	fusidic acid
BGC0001074.1|Cosmomycin_15 # 14604 # 15389 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.730	BGC0001074.1|Cosmomycin_15 	14604	15389	+	Loose	400	26.1794	VIM-61	30.93	3005509	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGTCCGCACAACCCAGCCGGGTTGCCGTCGTCACCGGTGCCACCAGCGGGATCGGCCTCTCCGTCGCCCGGGCGCTGGCCGCCGCCGGCCACCGCGTGTACCTCTGCGCCCGGGACGCCGACCGGGTCGCGCTCACCGTCAAGGAACTGCGCGCCGAGGGCCACGAGGTGGACGGCGCCGCCTGCGACGTGCGCGAGGTCGCGCAGATCGAGGCCCTGATGTCCGCCGCCGTGGAGCGCCACGGGCCCGTCGAGGTGCTCGTGAACAACGCCGGCCGCAGCGGCGGCGGACCGACCCACACGATCACCGACGAGCTGTGGGACGACGTGATGGCCACCAACCTGGACAGCGTCTTCCGCGTCACCCGGGCCGCCCTGACCACCGGCCGCATGCGGGAGGGCGGCTGGGGCCGGATCGTGAACATCGCCTCCACCGGCGGCAAGCAGGGCGTGGTGCTCGGCGCCCCCTACTCCGCCTCCAAGCACGGCGTCGTCGGCTTCACCAAGGCCCTGGGCCTGGAGCTGGCCAAGACCGGCATCACGGTCAACGCGGTCTGCCCCGGTTACGTGGAGACCCCCATGGCGGAGCGGGTCCGGCAGGGCTACGCCGCCGCCTGGGACACCACGGAGGAGGAGGTCCTCGACCGGTTCCAGGCCAAGATCCCGCTCGGCCGCTACACCACGCCCGACGAGGTGGCGGGCATGGTCGGCTACCTGCTGACCGACGCGGCCGCATCCGTCACCGCGCAGGCGATCAACGTCTGCGGCGGGCTGGGCAACTACTGA	MSAQPSRVAVVTGATSGIGLSVARALAAAGHRVYLCARDADRVALTVKELRAEGHEVDGAACDVREVAQIEALMSAAVERHGPVEVLVNNAGRSGGGPTHTITDELWDDVMATNLDSVFRVTRAALTTGRMREGGWGRIVNIASTGGKQGVVLGAPYSASKHGVVGFTKALGLELAKTGITVNAVCPGYVETPMAERVRQGYAAAWDTTEEEVLDRFQAKIPLGRYTTPDEVAGMVGYLLTDAAASVTAQAINVCGGLGNY	MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGYVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE	98.49	gnl|BL_ORD_ID|4639|hsp_num:0	5710			273	540	
BGC0001074.1|Cosmomycin_16 # 15398 # 16756 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=5bp;gc_cont=0.733	BGC0001074.1|Cosmomycin_16 	15398	16756	+	Loose	400	29.6462	SFH-1	55.0	3000849	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SFH beta-lactamase	ATGTCGGACGAGACCGCGCACCACACCGTCCACGAGATCGACGTGCGAGCGCCCGCCGAGGCGGTGTTCGACCTCGTCGCCGAGGCTTCCCGCTGGCCGGTGCACTTCCCGCCGAGCGTCCACGTCGAGCGACTGGAGGGCGACGACAGCCAGGAGCGGCTGCGGATCTGGGCCACGGCCAACGGCGAGGTCAAGAGCTGGACCTCGCGCCGTGAACTCGACCGAGCCGGACTGCGCGTGGCGTTCCGCCAGGAGGAGTCCCGGGCGCCCGTGCGGAGCATGAGCGGGGAGTGGCGGCTGGAGCCGCTCGGACCGGAGCGGACCCGGGTGCGCTTCACCCACACGTTCACGGCCGTCGACGACGCCCCGGAGCACGTCGAGTGGATCAACCGGGCCATCGACACCAACACCGCGTCGGAGCTGGAGGCGCTGCGCCGGGGCGCGGAGGAGGCGGACGCCGGCCTCACCTTCACCTTCGACGACAGCGTGCGCGTCGACGGATCGGCCAAGGACGCCTACGAGTTCATCCGCGCCGCGGACCGCTGGACGGAGCGGCTGCCGCACGTCGCCCGGGTCGTCCTCACCGAGGACACCCCGAACGAGCAGATCCTGGAGATGGACACGCTCACCGCCGACGGCGAGACCCACACCACCCGTTCGGTGCGGGTCTGCTTCCCCGCCGAGCGGATCGTCTACAAGCAGATCCGGACCCCTGCGCTGATGGCCGCGCACACCGGCGAGTGGATCTTCGAGGAGGACGAGCGGGGCTGCACGGTCACCTCCCGGCACACCGTGCGGATCGAACCGGACGCCGTGACCACCGTCCTCGGCCCGCAGGCCGACGTGGCCGCCGCCCGCACCATGATCCGGGAGGCGCTCGGCCGCAACAGCCTGGCCACGCTGCGGCACGCGGCGGAGCACGCGAAGCGGCGGGGCGGCACCGAGCCGGTCTCCGCGCAGACGTATGTCGCCGTGCAGCAGTTCTACGCCCGGCAGATGCGGCTGCTGGACGAGCGGCGGGCCGAGGAGTGGGCGCGGACCTTCACCGAGGACGGCGTGTTCGCGCAGAACACCGCCCCCGAGCCCCTGCGCGGCCGGGAGGCCGTCGCCGCCGCCGTACGCCGGAACCTGGCGCGGACGGCGGACACGCCGGAGCAGCGGCGCCACGTGTTCTCCATGCTCACCGTGGTGCCCGGGCCCGGCGGCTCCCTCCACACCCGCTGCTACGCGCAGGTCCTGGCGACCCCGCCCGGGGGGCAGAGCAGGCTGCACCTGAGCGCGGTGTGCGAGGACGAACTGGTACCGGACGGCGACGACTGGCTGGTCCGCCACCGCAGGGTCGAGCACGACGGCGGCTGA	MSDETAHHTVHEIDVRAPAEAVFDLVAEASRWPVHFPPSVHVERLEGDDSQERLRIWATANGEVKSWTSRRELDRAGLRVAFRQEESRAPVRSMSGEWRLEPLGPERTRVRFTHTFTAVDDAPEHVEWINRAIDTNTASELEALRRGAEEADAGLTFTFDDSVRVDGSAKDAYEFIRAADRWTERLPHVARVVLTEDTPNEQILEMDTLTADGETHTTRSVRVCFPAERIVYKQIRTPALMAAHTGEWIFEEDERGCTVTSRHTVRIEPDAVTTVLGPQADVAAARTMIREALGRNSLATLRHAAEHAKRRGGTEPVSAQTYVAVQQFYARQMRLLDERRAEEWARTFTEDGVFAQNTAPEPLRGREAVAAAVRRNLARTADTPEQRRHVFSMLTVVPGPGGSLHTRCYAQVLATPPGGQSRLHLSAVCEDELVPDGDDWLVRHRRVEHDGG	MASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGITIIGATWTPETAETLYKEIRKVSPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYDLQKSQWGSIVNFTRQGNNKYPNLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVYFPAERVLYGNCILKENLGNMSFANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDVGLIDHYLTLLEKAPK	193.16	gnl|BL_ORD_ID|2314|hsp_num:0	347			441	501	
BGC0001074.1|Cosmomycin_17 # 16844 # 17503 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.738	BGC0001074.1|Cosmomycin_17 	16844	17503	-	Loose	700	27.7202	CMY-143	34.38	3005204	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	GTGCTCGTCGTCGGCCGTACCGCGGCCGCCCTCGACGAGACGGCCGAGGGCCACGACGGCATCCGCACCCTCGTGGCCGACGTCACCGAGCCGGGGGCCGGCGAGGCGGTGGTGGAGGCGGCGCTGCGGGCCTTCGGACGCGTCGACGTGCTGGTCAACAACGCCGGGACCGGCACGTTCGCGCCGCTCGCCAAACTGGACCGGGCCGCGACCGAGCACCAGCTCGCGGTCAACCTGCTGGCGCCGGCCTTCGTCGCGCAGGCCGCCCTGGACGCCCTGGAGGCGACCGGCGGCACCATCGTCAACGTCAGTTCCGCGGGCTCGCTGGGCATCCAGGGGTTCCCCGACAACTCGGTGTACTGGGCCACGAAGGCGGCGCTGAACCACTTCACCCGTACCTGGGCCGTGGAGCTCGCGCCGCGCGGCATCCGCGTGGTGTCGGTGGCTCCGGGTGTGACGGACACCGGCATCGGCGAGCGCGTCGGCATGTCCGCCGAGGAGTACCAGGGGTTCCTCGGGCAGATCTCGGAGCGCATCCCGCTCGGGCGGGTCGCCACCCCCGAGGACGTGGCCTGGTGGGTCACGGCGCTGGCCGATCCCGGGGGCCGCTACATGACGGGCGCGGTCGTCCCGGTGGACGGCGGTCTCTCCCTCACCTGA	MLVVGRTAAALDETAEGHDGIRTLVADVTEPGAGEAVVEAALRAFGRVDVLVNNAGTGTFAPLAKLDRAATEHQLAVNLLAPAFVAQAALDALEATGGTIVNVSSAGSLGIQGFPDNSVYWATKAALNHFTRTWAVELAPRGIRVVSVAPGVTDTGIGERVGMSAEEYQGFLGQISERIPLGRVATPEDVAWWVTALADPGGRYMTGAVVPVDGGLSLT	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFDALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	57.48	gnl|BL_ORD_ID|2873|hsp_num:0	3891			396	576	
BGC0001074.1|Cosmomycin_18 # 17600 # 18037 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.756	BGC0001074.1|Cosmomycin_18 	17600	18037	-	Loose	525	26.9498	OKP-B-19	36.59	3002452	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGGACAGCACGGACATCCAGCAGTTCTACGCCCGCCACATGCAGCTGCTCGACGGTGGCGAGGCCGGGGCGTGGGCCGCCACGTTCACGCCCGACGCCACGTTCGCGTCGCCGTCGATGACGGAGCCGGTCCGGGGCCGGGAGGGCATCGCCGCCGGCGCGCGGGCGGCGGCCGAGGGGCGGGCGGCCGCCGGGGAGGTGCATCGCCACTGGGTCACCATGACGACCGCCCGGAGCACCGCCGACGGGATCGAGGCCGTCTCCTGCGTGCAGATCCTGGCGACCCCCCGGGGCGGCGCCCCGCGGGTGCACCTGTCCTGCGTGATGCGCGACCGGCTGGTCCGGCGGGACGGCGAACTGCTGGTGGCGGAGCGGCACATCACCCGGGACGACCGGCCGGACGAAGGGGTCGACCGCGCTTCGAGCGGTCGTCAGTAG	MDSTDIQQFYARHMQLLDGGEAGAWAATFTPDATFASPSMTEPVRGREGIAAGARAAAEGRAAAGEVHRHWVTMTTARSTADGIEAVSCVQILATPRGGAPRVHLSCVMRDRLVRRDGELLVAERHITRDDRPDEGVDRASSGRQ	MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR	50.70	gnl|BL_ORD_ID|982|hsp_num:0	1073			45	168	
BGC0001074.1|Cosmomycin_19 # 18186 # 18965 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.719	BGC0001074.1|Cosmomycin_19 	18186	18965	+	Loose	500	25.0238	GOB-35	33.33	3005684	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	GTGCGCATCATTGACCTGTCCTCGCCGGTGGACTCCGGCTCGTTCGAACCGGACCCGGTGGTCCACGAGGTGATGTCCCCGCGTGAGGGCGCGCTGCACATGCGCGACGAGATGCGGGAGCACTTCGGCATCGAGTTCGACCCCGACGTCCTGCCCGACGGCGAGTTCCTCTCGCTGGACCGGCTGAGTCTGACCACCCACACCGGCACGCACGTCGACGCGCCCTCGCACTACGGCTCGAGGACGACGTACGGCACCGGCGTGCCCCGGCACATCGACGCGATGCCGCTGGAGTGGTTCCTCGCCCCCGGGGTGGTCCTGGACGTCCGGGGCCGTGAGGCGGGCACGGTCGACGCGGCCGACCTGCGCAAGGAGCTCGACCGGATCGGGTACGCGCTCGCCCCGTCCGACATCGTGATCCTGCACACCGGCGCCGCCGCGTGGTCGGGCACCAGCCGGTACTTCACCGACTTCGTCGGTCTCGACGCGAGCGCCATCGCCTTCCTGCTCGACGCGGGCATCCGGGTGGTCGGCACCGACGCGTTCAGCCTGGACGCGCCGTTCGGCACGATCATCGCCGAGTACCGGCGGACCGGGGACCCCGCCGTGCTCTGGCCGGCCCACGTCGCCGGACGCCACCGGGAGTACTGCCAGATCGAGCGGCTCTCGGGACTGGAGAACCTGCCCGCGCCGTACGGCTTCCAGGTGTCGTGCTTCCCGGTGAAGATCGCCGGCGCCGGCGCCGGCTGGGCGCGGGCGGTCGCCCTCGTCGACGACTAG	MRIIDLSSPVDSGSFEPDPVVHEVMSPREGALHMRDEMREHFGIEFDPDVLPDGEFLSLDRLSLTTHTGTHVDAPSHYGSRTTYGTGVPRHIDAMPLEWFLAPGVVLDVRGREAGTVDAADLRKELDRIGYALAPSDIVILHTGAAAWSGTSRYFTDFVGLDASAIAFLLDAGIRVVGTDAFSLDAPFGTIIAEYRRTGDPAVLWPAHVAGRHREYCQIERLSGLENLPAPYGFQVSCFPVKIAGAGAGWARAVALVDD	MKRITTLLFLLVCFGWNAQTVKEPENTPKEWSQNYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGLAGSLSTIKENIAKLGFNYKDIKILLLTQAHYDHTGALMDFKTETGAKFYADAADADVLRTGGQSDYEMGKYGATFKPIIPDRTLKNLDKIKLGNTTLTMLHHPGHTKGSCSFVFDTNDGKRKYRVLIANMPSIIVDNKFSEVTAYPNIQSDYAYTFNAMKKLDFDIWVASHASQFDLHEKRKEGEPYNPQLFMDKQNYFQNLNNLEQSYRDKIKKDSQDK	89.31	gnl|BL_ORD_ID|3579|hsp_num:0	4648			420	525	
BGC0001074.1|Cosmomycin_21 # 19761 # 20870 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.705	BGC0001074.1|Cosmomycin_21 	19761	20870	+	Loose	1000	25.409	eptB	50.0	3005047	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCACCTACGTCTGGGACTACTTGCGGGAGTACGCCGAGGAGCGCGAGGAACTCCTCGACGCCGTCGACACGGTGTTCCAGTCCGGTCAGCTCGTCCTCGGCGAGAGCGTCTCCCGCTTCGAGCAGGAGTTCGCCGCCTACCACGGGCAGCCGCACTGCGTGGGCGTGGACAACGGCACCAACGCGATCGTCCTCGGCCTGCAGGCGCTCGGGGTGAAACCCGGCGACGAGGTGATCACGGTCTCCAACACGGCGGCCCCCACCGTGCTGGCCATCGACGCCGTCGGCGCCCGGCCGGTCTTCGTCGACGTGCGCGAGGAGGACTACCTCATGCGCACCGACCAGCTCGCCGGCGCGCTCACCGAGCGCACCGCGGCCATCGTGCCCGTGCACCTGTACGGGCAGTGCGTCGACATGGCCGCCGTGACCGCCTTCGCCGAGCGCCACGGACTGAAGGTCCTGGAGGACTGCGCCCAGGCCCACGGCGCCCGGCACCACGGCCGGCTGGCCGGGACCATGGGCGACGCCGCGGCCTTCTCCTTCTACCCGACGAAGGTGCTCGGCGCGTACGGCGACGGCGGTGCCGTGGTCACCCGCGACGACGGCACGGACGCGAACCTGCGCCGGCTGCGCTACTACGGCATGGAGGACCGGTACTACGTTGTCCAGACCCCCGGGCACAACAGCCGCCTCGACGAGGTCCAGGCCGAGATCCTCCGCCGCAAGCTCCGGCGCCTCGACACCTACGTCGAGGGCCGGCGGCGCGTGGCGCGACGCTATGCGGAGGGGCTGGCGGACACCGGCCTCGTCCTTCCCGCGAACGCGGTGGGCAATGATCACGTCCACTACGTCCACGTGGTCCGCCACCCCGAGCGGGACCGCATCATCGAGCGGCTCAGGGCGTACGACATCGAGCTGAACATCAGCTACCCCTGGCCGGTGCACACGATGAGCGGCTTCGCACACCTCGGGTACCGCGAGGGCGACCTGCCGGTGACCGAGCGGCTGGCGAAGGAGATCTTCTCCCTGCCGATGTACCCCTCGCTGCCGCAGCACGTCCAGGAGAAGGTGATCGAGGCGCTCCGCGAGGTGATCGCCGGGCTCTGA	MTTYVWDYLREYAEEREELLDAVDTVFQSGQLVLGESVSRFEQEFAAYHGQPHCVGVDNGTNAIVLGLQALGVKPGDEVITVSNTAAPTVLAIDAVGARPVFVDVREEDYLMRTDQLAGALTERTAAIVPVHLYGQCVDMAAVTAFAERHGLKVLEDCAQAHGARHHGRLAGTMGDAAAFSFYPTKVLGAYGDGGAVVTRDDGTDANLRRLRYYGMEDRYYVVQTPGHNSRLDEVQAEILRRKLRRLDTYVEGRRRVARRYAEGLADTGLVLPANAVGNDHVHYVHVVRHPERDRIIERLRAYDIELNISYPWPVHTMSGFAHLGYREGDLPVTERLAKEIFSLPMYPSLPQHVQEKVIEALREVIAGL	MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	64.29	gnl|BL_ORD_ID|2778|hsp_num:0	3791			1269	1323	polymyxin B; colistin A; colistin B
BGC0001074.1|Cosmomycin_23 # 22399 # 23403 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GAGGAG;rbs_spacer=5bp;gc_cont=0.765	BGC0001074.1|Cosmomycin_23 	22399	23403	-	Loose	200	26.9498	vanH gene in vanO cluster	45.65	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGGCAGTCCTCCGGCATCGGCGCCTCGAGCTGAGCACGGCGATGTCCACCACCACGCAGGGCGGGGCGGCCGTCGGCACCGTGGCCGTGCTCGGCGCCACGGGGTGCGTCGGCCGCAGCGTCTGTGACGAACTGTCGCGCACCGGGCACCGGGTGCTGGCGGTGGCCCGGCACCCGGCGCCCCACACCCGCCCGCACGCCTTCGTCCCCCTCGACGTCGCCGGGACCGCGCCGGAGCGTCTCGCCGCGCTCCTCGACCGGTACGGCGTCACCGCGGTGGTCAATGCCACCGGCGGCTGGGGCACCACCGTCGAGGAGATGCGCCGGGCCCACATCGACCTCCTGGAGCGCCTGGTCGACGGCTGTGCCGCGACCTCCCGGCGGCTGCGGGTCGTCCAGCTGGGGTCGATCCACGAGTACGGGCCCGTGCCGGACGGCGTCCTCATCGACGAACACCGCGAGCCCGGCCCGCTCACCCCCTACGGACTGACCAAGCGCACCGGGTCCGAGCACCTGCTGGCCCAGACCCGGGCGGGCCGGGTGGACGGGGTGGTGCTGCGCGCGGTCAACGTGTGCGGGCCGCACACCACGACGGCCAGCTTCCTCGGCGCCGTCGTGGCCCGGCTGCGCGCCCTCGGCCCCGGCGACGAGCTCAGCCTCGACGTCGCCGACGCCCGGCGGGACTTCGTCGACGTGCGGGACCTGGCCCGGGCGGCCGTCGCCGCGGTGCACGCGCCGGTCACCGGCCTGGTCGTGAACATCGGGCGCGGCGAGGCGGTGCCGATGCGCGACCTGGTGCAGGCCCTGTTCGACGCGGCCGGCGTGGACGCCTCGTCGGCGCGGCTCAACTCCGCCGAGGTCGCCAGCAAGGGCGGCGGCTGGACCTGCGCGGACATCCGGTTCGCCGCCCAGGTGCTCGGCTGGCGGCCCACGATCCCGCTCGGCGCCTCGGTCCGGGCGATGTGGGAGGCGGCAGCCGGCACCACCCCCCTGGAGGTCTCATGA	MAVLRHRRLELSTAMSTTTQGGAAVGTVAVLGATGCVGRSVCDELSRTGHRVLAVARHPAPHTRPHAFVPLDVAGTAPERLAALLDRYGVTAVVNATGGWGTTVEEMRRAHIDLLERLVDGCAATSRRLRVVQLGSIHEYGPVPDGVLIDEHREPGPLTPYGLTKRTGSEHLLAQTRAGRVDGVVLRAVNVCGPHTTTASFLGAVVARLRALGPGDELSLDVADARRDFVDVRDLARAAVAAVHAPVTGLVVNIGRGEAVPMRDLVQALFDAAGVDASSARLNSAEVASKGGGWTCADIRFAAQVLGWRPTIPLGASVRAMWEAAAGTTPLEVS	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	95.43	gnl|BL_ORD_ID|761|hsp_num:0	786			528	654	vancomycin
BGC0001074.1|Cosmomycin_25 # 24070 # 25362 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.705	BGC0001074.1|Cosmomycin_25 	24070	25362	-	Loose	700	48.9062	oleI	30.37	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGGTACTCTTCACCACCTTCGCCGCCAAGTCGCACATGCACGCCCAGGTCACACTCGCCTGGGCCCTCAAGGCGGCGGGCCACGACGTCAGGATCGCCAGTCACCCCGATCTCGCCGACGAGATCACCCGTACCGGGCTGACCGCCGTCGGGGTCGGGGAGGAACTGCATCTCGACGAGCAGATGCAGGAGACCCAGGAGAACATCGGCCAGGACGTCGACCAGCTGGAGAGCCAGGCACAGGTCGGTCTCGACATGAGCGAGACCCGCCCGGAGCGGCTCACCTGGGACTACACACTCGGTGTGTTCACGGCCATGACCTCGGTCGTCTTCCAGAACTGCTGCTCCGACCAGATGGTCGACGAGCTGGTGGAGCACTGCCGCTCCTGGAAGCCCGACCTGGTCCTGTGGGACACCATGACCTTCGCGGGCGCCATCGCCGCCATGGCCACGGGGACGGCGCACGGCCGGCTGCTCTTCGGGATGGACCTGGCGGGCAAGATGCGCGAGACCTTCCTGGAGCAGCTGGCGGCGCGTCCGCCGGAGCTGCGGGACGACCCGCTGCGCGAGTGGCTCACCTGGAGCCTGGAGCGGCACGGCGCCTCCTTCGAGGAGGCCGCGGTGACGGGCGACTTCACCGTCTGCCCGCTGCCGGCGTCCATGCGGTTCCCGCTGGACCTGCACTACGTGCCGATGCGGTACGTGCCGTACAACGGCCAGTCCACCGTGCCGCAGTGGCTCCAGGAACCGCCGAAGCGGGGCCGCCGGGTGTGCATCACGCTGGGTGTGGCGCACCGCGAGGTGCTGGGCGCCGACCGGGCGTCCATCGGCGACCTGCTGGAGGCCGTCGCGGGGCTCGACGACGTCGAGGTCGTCGCCACGCTCAACGAGAACCAGCTGAAGGACTTCGACACCCTGCCGGACAACGTGCGGGCCGTCGACTTCGTCCCGCTCGACGCGCTGCTGCCCACCTGCGACGCGGTGATCCACCACGGCGGGTCGGGCAGCTTCGGCACGGCGATGATCCACGCCGTGCCCCAGCTCATCGTCGTCGACGGCGTCTGGGACACCATCAACAAGGCCCGCTACCTGGAACGGCGCCAGGCCGGGCTCTACGTGCCCGGCAAGCTCAGCGCGAAGGGACTGCGCGAGCTGCTCGTCCGCCTGCTCGAGGAACCGGTCTTCAAGCGCAACGCCGAGGCCCTGCGGCGCGAGGCGCTCGCCGCTCCCGCCCCCGCGCAGGTCGTCCCCACGCTGGAGCGCCTGGCCGCCGAGCACCGCCGCCGGTGA	MRVLFTTFAAKSHMHAQVTLAWALKAAGHDVRIASHPDLADEITRTGLTAVGVGEELHLDEQMQETQENIGQDVDQLESQAQVGLDMSETRPERLTWDYTLGVFTAMTSVVFQNCCSDQMVDELVEHCRSWKPDLVLWDTMTFAGAIAAMATGTAHGRLLFGMDLAGKMRETFLEQLAARPPELRDDPLREWLTWSLERHGASFEEAAVTGDFTVCPLPASMRFPLDLHYVPMRYVPYNGQSTVPQWLQEPPKRGRRVCITLGVAHREVLGADRASIGDLLEAVAGLDDVEVVATLNENQLKDFDTLPDNVRAVDFVPLDALLPTCDAVIHHGGSGSFGTAMIHAVPQLIVVDGVWDTINKARYLERRQAGLYVPGKLSAKGLRELLVRLLEEPVFKRNAEALRREALAAPAPAQVVPTLERLAAEHRRR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	101.42	gnl|BL_ORD_ID|1684|hsp_num:0	1824			714	1266	oleandomycin
BGC0001074.1|Cosmomycin_26 # 25609 # 26172 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.715	BGC0001074.1|Cosmomycin_26 	25609	26172	+	Loose	535	27.335	aadA10	35.14	3004692	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGTCCGCCACGCGATTGCTCGTCCTGGGGGTCGTGCGGATGCACGGCCGGGCGCACGGCTATCTGGTCCGCTCCGAGCTGTTGTCCTGGGGTGCCGACGAATGGGCGCACATCAAGTTCGGCTCGATCTACCACGCGCTCAGGCAGCTGGCCAAGGACGGCCTGCTGAAGTCGACCGACATCCCCGACTGGCCCGGCCGCGTCGACTACGAGATCGCGCCCCCGGGCGAGGAGGAGTTCTTCCGGCTGCTGCGCGACGCGCTGCGCCAGGGGAACAACCGACCGGACATGCTGGGGGCGGCGCTCGTCCTGCTGCCGGCGCTCAGCCGCGAGGAGGCGATCGCCCTGTTGCGGGAGCGCATCGCGTCGCTCTCGGCGGAGCAGGGTGAGCTGATCGCGAAGGTCGACGAGACGGCGGGCGAGCGGCCGCAGCGGGCCCACATCCGCGAACTCCTCGGCCTCTGGGAGCACAGCGCCGCGAGCCAGGCCGCCTGGACCGAGGCACTGATCGAGCGCCTGGAGGCGGGCGCCTACGTCATGGCGGGGGAGGAGAAGGGCGCCTGA	MSATRLLVLGVVRMHGRAHGYLVRSELLSWGADEWAHIKFGSIYHALRQLAKDGLLKSTDIPDWPGRVDYEIAPPGEEEFFRLLRDALRQGNNRPDMLGAALVLLPALSREEAIALLRERIASLSAEQGELIAKVDETAGERPQRAHIRELLGLWEHSAASQAAWTEALIERLEAGAYVMAGEEKGA	MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDESVRQALFVDLLGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWIGDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEARQAYLGQGEDCLASLTDQLEAFVHFVKHEATKLLGATPMMSKTKLDALST	67.51	gnl|BL_ORD_ID|2153|hsp_num:0	3398			465	576	spectinomycin; streptomycin
BGC0001074.1|Cosmomycin_28 # 27374 # 27709 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=10bp;gc_cont=0.714	BGC0001074.1|Cosmomycin_28 	27374	27709	+	Loose	2000	24.2534	adeJ	42.11	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCAGCCGATCAGCCCGGCCCCGCCTCCGGCGGCCCGGCCACCTTCGTCAACAGCTTCACCCTCCGCACCACCCCGGAGGAGTTCGAGGACGTCTTCGCCCGCACGGCACGCTTCATGGAGCGCCAGCCCGGCTTCCTCGGCTACACCCTCGTACGCCACCTGGAACAGCCGCACAGCTACGTCAACATCGCCCGCTGGGCCGACGTCGCCTCCTTCCGCGCCGCGGTCGGCCAGAGCGACTTCCGGCCGCACGCCGAGGCGCTGCGGGCGATCAGCACCAGCAGCTCCAACCTCTACCTGGAGCGGCGCAGCGCCACCGGGGAGGCGCGATGA	MSADQPGPASGGPATFVNSFTLRTTPEEFEDVFARTARFMERQPGFLGYTLVRHLEQPHSYVNIARWADVASFRAAVGQSDFRPHAEALRAISTSSSNLYLERRSATGEAR	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	10.49	gnl|BL_ORD_ID|574|hsp_num:0	630			699	756	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0001074.1|Cosmomycin_30 # 28971 # 30215 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.761	BGC0001074.1|Cosmomycin_30 	28971	30215	+	Loose	600	33.113	MSI-1	34.38	3003718	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI beta-lactamase	ATGACCCCCGTCGTGGTCACGGGCATCGGCGTCGTCGCCCCCACCGGCATCGGACTCGACGCCTACTGGGCGGCGACCCTGCGCGGCGACGACGGCATCCGGCGCGTGCAGGCGTTCGACCCCAGCCGCTATCCGACCCGCCGGGCCGGGGAGGTGACCGGGTTCGAGGCGGGCGACCACCTGCCGAGCCGGCTGATCCCGCAGACCGACCGCATGACCCAGTTCGCCCTGGCCGCGGCCGACTGGGCCGTCGCCGACGCCGGCATCGACCTCGACGCGGTGCCGTCGCTGGAACGCGGCGTCGTCACGGCCGGTGCCTCCGGCGGCTTCGGCTTCGGCCAGCGCGAACTCCAGCACCTGTGGGGCGAGTCCCCCAAGAAGGTCAGCGCCTACATGTCCTTCGCCTGGTTCTACGCCGTCAACACCGGCCAGATCTCCATCCGGCACGGCATGAACGGGCCGACCGGCGTCTTCGTCGGCGAGCAGGCCGGCGGCCTGGACGCCCTCGCCCACGCCCGGCGCCAGATCCGCGCGGGGGCCCGGCTGATGATCTCCGGCGGCATGGACTGCTCCCTGTGCCCGTACGGCATGGCCGCCCAGCTGGCCGGCGGACGGCTCACCGCCGACGCCTACCTGCCCTTCGACGACCAGGCCTCCGGTCATCTGCCCGGCGAGGGCGGGGCGTTGCTCACCCTGGAGAGCGCCGAGGGGGCCCGGGCGCGCGGACGCGGTCACTACGGCGAGATCGCCGGGTTCGGCGCCACCTTCGACCCGCGCCCCGGGTCCGGGCGCCCCCCGGCCCTGCGCCGGGCCGTCGAGCAGGCGCTCGCCGACGCCCAAGCCGCGCCGGAGGACATCGCCGTCGTCTTCGCCGACGGTGCCGGCGTGCCCGAACTCGACGCGGCCGAGGCCGCGGCGCTCACCGAGGTCTTCGGCCCGGGAGGAGTCCCGGTCACGGTGCCCAAGACGGCCACCGGCCGGCTCTACTCCGGTGCCGGGCCGCTCGACGTGGTCACCGCCCTGCTGACCCTGCGCGACGGGATCGCCCCGCCCACGGTCAACGTCTCGCGGGTGCCCGACACGTACGGCCTCGACCTCGTCCTCGGACGGCCCCGGCCGGTCTCCGGCACGGCGGCCCTGGTCCTGGCCCGCGGCCACCACGGCTTCAACAGCGCCCTGGTCGTCCGGGCCCCCGCGCCCGGCGACGCCGTCGCGCACCGGCCCGAGGAGAGGACGGCGGCGTGA	MTPVVVTGIGVVAPTGIGLDAYWAATLRGDDGIRRVQAFDPSRYPTRRAGEVTGFEAGDHLPSRLIPQTDRMTQFALAAADWAVADAGIDLDAVPSLERGVVTAGASGGFGFGQRELQHLWGESPKKVSAYMSFAWFYAVNTGQISIRHGMNGPTGVFVGEQAGGLDALAHARRQIRAGARLMISGGMDCSLCPYGMAAQLAGGRLTADAYLPFDDQASGHLPGEGGALLTLESAEGARARGRGHYGEIAGFGATFDPRPGSGRPPALRRAVEQALADAQAAPEDIAVVFADGAGVPELDAAEAAALTEVFGPGGVPVTVPKTATGRLYSGAGPLDVVTALLTLRDGIAPPTVNVSRVPDTYGLDLVLGRPRPVSGTAALVLARGHHGFNSALVVRAPAPGDAVAHRPEERTAA	MGARSCSRAWCCSRATRSAPPGRRSGRLSCARCRRPSTGCNPSSTPPITGDIMKHIRLACVAAGLVAAASSVSAIGADWNAPQEPFALFGNSYYVGPHGVASVLITSNQGHILIDGGSDKSPPQIAARIRQLGFKPEDIRFILVSHEHIDHAGGVAELQRLSNAEVLAGAAAVPVLHSGEAGRNDPQYGGLPKMAPVARVRAVRDGEVVKLGPLAVTMHATPGHTQGGASWTWQSNEGGRTANMVYADSLTAFGSGGFRYSGDARYPSARADVERSIAKVAALPCDILVSAHPEVSELWTRYERRAAQGNAAFIDAGACKAYAVKARVKLQEQLARETAKP	121.41	gnl|BL_ORD_ID|2030|hsp_num:0	2233			675	867	
BGC0001074.1|Cosmomycin_32 # 31243 # 32292 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.783	BGC0001074.1|Cosmomycin_32 	31243	32292	+	Loose	400	26.5646	Erm(30)	50.0	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACGACGTCCGCACGGCAGCGGACGGGCGGGACGGCGGTACGCGCCCGGTCGCCCTGCTGCTGCCCGGCCAGGGAGCACAGCACCCGCGCATGGCGGCGGGCCTCCTGGCCGCCGAGCCCGTCTTCGCGGAGGCGATGGACGAGGCCCTGACCGCCCTGGCGGACGCCGGTGGGCCGGGCGGCCACGGCACCGGCCTGCGCGAGGACTGGCTCGGGTCCCGCGACACCGCGCTGATGGACCACGTCACGCGCTCCCAGCCCCTGCTCTTCGCGGTGGACTACGCCATCGGGCGGCTCGTGCTCGGCTGGGGCGTGCGGCCCGTCGCCCTGCTCGGCCACAGCATCGGCGAGGTGGCGGCCGCGGTCCTCTCCGGCGTCTTCACGCTGCCGGACGCCGCCGCCATGGTGCACGACCGCGTCGCCCGGCTGGCGGACGCGCCGCCCGGCGGGATGGTCGCCGTCGCCGCCACCCGGGAGGAGGTGGCGCCCTTCCTCACCGACGGCGTGGTCGTCGGCGCCGTCAACGCCCCGCGGCAGACGGTCCTGGCCGGACTCGACGGCCCGCTGCGCACCGTCACGGCGGCACTGGCCGACGCCGGGTTCGTGCTCCAGCGCGTACCCGCCTCCACGGCGTTCCACAGCCCCGCCCTCGCCCCGGCGATGCGCGGTGCCGACGAGCGGATCGCCGCCCTGCCCGTCGGCGAGCCCCGGATCCCGGTCATGTCCGGGTACACGGGCCGGTTCCTGACGCCCGCGGAGGCGAAGGACCCGGCCTTCTGGAGCAGGCAGCCGGTGGCGCCGGTGCTGTTCTGGCCCGCCCTCGACGCCCTCCTCGCCCAGGGCGACCCGGTGCTCGTGGAGGCCGGTCCGGGGCAGGGGCTGTCGCAGCTGGCCCGCCGCCACCCGGCCGTGCGCTCCGGCCGCTCCGCCGTCGTCCCGCTGCTGCCGGCCCGGCCGGGAACCGCCGAGGACGACGTGACCGCCGTACGCGCCGCCGCCGCGGCGCTACGGGAACGCGCCGGCGTACCGGACGCGCGGCCCGTGTAG	MNDVRTAADGRDGGTRPVALLLPGQGAQHPRMAAGLLAAEPVFAEAMDEALTALADAGGPGGHGTGLREDWLGSRDTALMDHVTRSQPLLFAVDYAIGRLVLGWGVRPVALLGHSIGEVAAAVLSGVFTLPDAAAMVHDRVARLADAPPGGMVAVAATREEVAPFLTDGVVVGAVNAPRQTVLAGLDGPLRTVTAALADAGFVLQRVPASTAFHSPALAPAMRGADERIAALPVGEPRIPVMSGYTGRFLTPAEAKDPAFWSRQPVAPVLFWPALDALLAQGDPVLVEAGPGQGLSQLARRHPAVRSGRSAVVPLLPARPGTAEDDVTAVRAAAAALRERAGVPDARPV	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	103.87	gnl|BL_ORD_ID|1123|hsp_num:0	1224			627	699	narbomycin; methymycin; pikromycin
BGC0001074.1|Cosmomycin_34 # 33721 # 35001 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=GAGGAG;rbs_spacer=7bp;gc_cont=0.724	BGC0001074.1|Cosmomycin_34 	33721	35001	+	Loose	700	55.8398	oleI	34.02	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGCGTGTACTGCTGACAGCCTTCGCACAGGACGCCCATCTCAACGGCATCGTTCCGCTCGCCTGGGCGCTGCGGACCGCCGGGCACGAGGTCCGGGTGGCCGGCCAGCCGGCCGCGGTCGAGAGCATCACCCGGGCCGGTCTGACGGCCGTGCCGGTGGGCGACGACCACCGGATGGACGCCGTCATCCCCACCGTCGGTCCCGGGATGCTCATGCACCACCTGGACCGCGACTACCTGGAGAACCGCCCGGAGCGGCTGAGCCTCGACTTCCTGCGGGCGTCGAACGCGATGCTGACGGCGACCTTCTACGCGCAGATCAACAACGACTCGATGATCGACGCGCTCGTCGACTACGCCCGGTTCTGGCAGCCGGACCTGGTGCTCTGGGAGCCCTTCACCTTCGCCGGCGCCGTCGCCGCCAAGGCGACCGGGGCCGCCCACGCCCGGCTCCTGGCCTTCCCCGACCTGTTCGCGAACACCCACCTGACGCTGCGCCGGCGGCAGGCGGAACTGCCCGCGGAACTGCGCGACGACCCGCTGGAGGAGTGGCTGGCGTACACCCTCGACCGGCACGGCGCCGCCTTCGACCCCGACGTGGTCACGGGGCAGTGGTCGGTCGACCAGATGCCCCCCGGCGTGCGGATGGAGCTGGGGCTGCCGACGGTGCCCACGCGTTACGTGCCGTACAACGGTCCGGGTCCGGCCGTCGTGCCGGACTGGCTGCGCCGGCCGCCGGAGCGCCGCCGGGTCTGCCTCACCCTCGGGCTCACCATCCGGGACACGGAGTTCCCCAACGCCGTCGACGTCGACGACGTCTTCGCCTCGCTGGCCGACCTGGACGTCGAGGTGGTGGCGACGCTGAGCGAGAAGGAACTCGCCCAGGTGTCGCGGGTGCCGGACAACACGCGGGTGGTCGACCACGTGGCCCTGCTGGCCCTGCTGCCCAGTTGCTCGGCGATCGTCCACCACGGCGGTGCCGGGACGTGGGCGACCGCCGCCGCGTACGGGGTGCCGCAGGTGGCGCTCGGCTGGATGTGGGACGCGATCTACCGCGCGCAGCGGGTGGAGGAGCTGGGGGCGGGGCTGCACCTGCACTCCGAGGGCCTGACCGTCGAGGTCCTGCGCGACAAGCTCGTGCGGGTGCTCGACGACCCCTCGTTCACGGAAGGCGCCCGACGGCTGCGTCTGGCCATGCTGTCGGCGCCGAGCCCCAACGAAGTGGTGCCCACACTCGAGAAACTGACGGCGCGTCACCGCTCGGTGGCCGCGGCCCGCTGA	MRVLLTAFAQDAHLNGIVPLAWALRTAGHEVRVAGQPAAVESITRAGLTAVPVGDDHRMDAVIPTVGPGMLMHHLDRDYLENRPERLSLDFLRASNAMLTATFYAQINNDSMIDALVDYARFWQPDLVLWEPFTFAGAVAAKATGAAHARLLAFPDLFANTHLTLRRRQAELPAELRDDPLEEWLAYTLDRHGAAFDPDVVTGQWSVDQMPPGVRMELGLPTVPTRYVPYNGPGPAVVPDWLRRPPERRRVCLTLGLTIRDTEFPNAVDVDDVFASLADLDVEVVATLSEKELAQVSRVPDNTRVVDHVALLALLPSCSAIVHHGGAGTWATAAAYGVPQVALGWMWDAIYRAQRVEELGAGLHLHSEGLTVEVLRDKLVRVLDDPSFTEGARRLRLAMLSAPSPNEVVPTLEKLTARHRSVAAAR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	100.47	gnl|BL_ORD_ID|1684|hsp_num:0	1824			891	1182	oleandomycin
BGC0001074.1|Cosmomycin_35 # 35024 # 36007 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GAGGA;rbs_spacer=10bp;gc_cont=0.712	BGC0001074.1|Cosmomycin_35 	35024	36007	+	Loose	1200	40.817	arnA	23.64	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGAACATCCTGGTGACCGGTGCGGCCGGCTTCATCGGCTCGCACTTCGTCAGAACGCTGCTGAGCGGCGGGTACCCCGGGCACGAGGACGACCGGGTGACCGTCCTGGACAAGCTCACCTACGCGGGGACGCTGAACAACCTGCCGGCGCACCACCCGCGGCTGACCTTCGTGCACGGCGACATCTGCGACACCACCCTGCTGGACAAGGTGTTCCCGGGCCACGAGGCGGTCGTCCACTTCGCCGCGGAGTCGCACGTCGACCGCTCGGTGGCGGGCGCCGAGGCCTTCGTCCGCACCAACGTGCTCGGCACGCAGGCCCTGCTCGAAGCGGCGCTGCGGCACGGGATCGGCGTCTTCGTCCAGGTCTCCACGGACGAGACGTACGGTTCCATCGCCGAGGGGCGCTGGACGGAGGACGAGCCGCTGCTGCCCAACTCGCCCTACGCGGCGTCCAAGGCGTCGGCCGACCTCATCGCCCGGTCGTACTGGCGCACCCACGGCCTCGACGTGCGCATCACCCGCTGCGCCAACAACTACGGCCCCGGCCAGCACCCCGAGAAGCTGGTCCCGCTGTTCGTCACCCGGCTCCTCGACGGGCAGCCGGTCCCGCTGTACGGGGACGGCTCGAACCTGCGCGAGTGGCTGCACGTGGACGACCACTGCCACGCGGTGCGGCTGGTGCTGGACCGGGGCCGGCCGGGGGAGGTCTACAACGTCGGCGGCGGCACCCACCTGACCAACAAGGAGATGACCGGCCGCCTCCTCGCACTCTGCGGACGCGACTGGGACCTCGTGCGGCGGGTGGCGGACCGCAAGGGGCACGACTTCCGGTACGCCGTGGACGACTCCAAGATCCGCCGCGAACTGGGCTACGCGCCCCGCTGGTCGCTCGAGGACGGGCTGCGCGAGACGGTCGAGTGGTACGCCGCCCACCGTGACCACTGGGACGCCCGGGAGGAAGGCGCCGACGAGGGGTACTAA	MNILVTGAAGFIGSHFVRTLLSGGYPGHEDDRVTVLDKLTYAGTLNNLPAHHPRLTFVHGDICDTTLLDKVFPGHEAVVHFAAESHVDRSVAGAEAFVRTNVLGTQALLEAALRHGIGVFVQVSTDETYGSIAEGRWTEDEPLLPNSPYAASKASADLIARSYWRTHGLDVRITRCANNYGPGQHPEKLVPLFVTRLLDGQPVPLYGDGSNLREWLHVDDHCHAVRLVLDRGRPGEVYNVGGGTHLTNKEMTGRLLALCGRDWDLVRRVADRKGHDFRYAVDDSKIRRELGYAPRWSLEDGLRETVEWYAAHRDHWDAREEGADEGY	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.40	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1701	polymyxin B
BGC0001074.1|Cosmomycin_36 # 36011 # 37072 # 1 # ID=1_36;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.694	BGC0001074.1|Cosmomycin_36 	36011	37072	+	Loose	650	322.013	tetA(58)	50.15	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGAATATCCGGGCCGCCCTCCTCTACGCTCGCCGGGTACACAAATTTGAGCACCCGAAAGAAGGGGCGGGCATGGGCGGCGCCGACCTGGCGATCCAGACCGAAGCTCTGAAGAAGAAATACGGCGACAAGGAGGCCCTCGCGGGACTCGACCTGGAGGTACCCCGAGGCGTCGTCTACGGGCTCCTCGGCCCGAACGGCGCCGGAAAGACCACCGCGGTCCGCATCCTCTCCACCCTGCTGAAGTACGACGAGGGAACAGCCCGGGTCGCCGGCTACGACGTCGCCACCCAGTCGGCCCAGGTCCGCTACAGCATCGGACTCCTCGGCCAGCACGCCGCAGTGGACGAGGACCTGAGCGGCCGTCAGAACCTCGTGATGTTCGGGCGCTTATACCACATCGGTAAACGCAACGCCCAGGCCCGGGCCGACGAACTGCTGGAGCGCTTCGGCCTCACCGAGGCCGCCGGCAAGCCGGCCAAGCAGTACTCCGGCGGTATGCGCCGGCGGCTCGACCTCGCCGCCAGCCTCATCCTGGCCCCGTCCGTGCTGTTCCTCGACGAGCCCACCACCGGGCTCGACCCGCGGGGCCGCAACGACGTCTGGGAGTCCGTCCGAGGCCTGATCGCCGAGGGCCGCACGGTCCTGCTGACCACCCAGTACCTGGAGGAGGCCGACCAGCTCGCCGACCGCATCGCCCTGATCGACAACGGCAGGGTCGTCGAGTCCGGCACCCCGGACCAGCTCAAGAACAAGATCGGCGGGGACCGGATCGACGTCGTCCTCCGCCGCGCCCACGACCTCGAACGCGCCACCCACACGATCGGCACCCTGCTGCGCTCCGAGCCCGAGACGGACGCCGACAACCGGCGCATCAGCGTCGTCGTCGACAACCGGGTCGCCGCCCTCACCGCCGTCGCCCGCGAACTCGACGACGCCGGCATCGAGGCCGAGGACATCGCCCTGCGCAGGCCCACTCTCGACGAGGTGTTCCTGAACCTGACCGGCAACGGGGCGGCCACGTCCGCCGAGCAGAGCCTCAAGGAGGTCGCCCAGTCATGA	MNIRAALLYARRVHKFEHPKEGAGMGGADLAIQTEALKKKYGDKEALAGLDLEVPRGVVYGLLGPNGAGKTTAVRILSTLLKYDEGTARVAGYDVATQSAQVRYSIGLLGQHAAVDEDLSGRQNLVMFGRLYHIGKRNAQARADELLERFGLTEAAGKPAKQYSGGMRRRLDLAASLILAPSVLFLDEPTTGLDPRGRNDVWESVRGLIAEGRTVLLTTQYLEEADQLADRIALIDNGRVVESGTPDQLKNKIGGDRIDVVLRRAHDLERATHTIGTLLRSEPETDADNRRISVVVDNRVAALTAVARELDDAGIEAEDIALRRPTLDEVFLNLTGNGAATSAEQSLKEVAQS	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	102.92	gnl|BL_ORD_ID|2243|hsp_num:0	2517			30	1002	tetracycline
BGC0001074.1|Cosmomycin_37 # 37069 # 37899 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.679	BGC0001074.1|Cosmomycin_37 	37069	37899	+	Loose	500	100.523	tetB(58)	27.9	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGCGATCATCGCGCCCGAACTGCCCAGGAACCCGCTGGCCAAACTGGGCTGGGTCCTCGCGGACTCCTGGACGCTCACGCTCCGCGGACTGTCCCACTGGGCCCGCAACCCCACCCAGATCCTGGCCGGCCTCGCCTTCCCGATCCTGATGGTGCTGCTGTTCGGCGGCATCTTCGGCAGCGGCATGCAGGTCGAGGGCGGCGGGGACTACATGGACTTCCTGATGCCCGGCATGTTCGTCATGTCGATGGCCTTCGGCATCGGCGAGACCATGGCCGGCGTCACCGCCGACGCCTCCAAGGGCGTCACCGACCGGTTCCGCTCCATGCCCATGTCCGCCGCCTCCGTGGTCATCGGGCAGAGCATCGTCAACATGCTCTACAGCACCGTGGTCCTGATGATCCTCATGGGCTGCGGGGTCATCGCCGGATGGAGCTGGAACGACGGGTTCATGCAGGCGCTCGGCGCCTTCGCGCTCCTGCTCCTGCTGCGCTTCGCCCTGCTCTGGGTCGGCATCTACCTCGGCCTGATCATCAAGACCCCGGAGGCCGCCTCCGCCGTCTACACCCTGCTGTTCCCGCTCGGCATCGTCGCCAACACCTTCGCCTCCCCGGAGATGATGCCGGGCTGGCTGGCGGCCATCGCCGAGTGGAACCCGCTGTCGTCCACCGCCCACGCCACCCGTGAGCTGTTCGGCAACCCCGGGGTGGGCGGCACCTCCTGGATCGCCGAGCACGCGATGCTCATGTCCTTCGTCTGGCCGCTCGCGATCTTCGCGGTGTTCTTCCCGCTGGCCGTCCGCAAGTACCGGGCCCTGAGCAGGTAA	MTAIIAPELPRNPLAKLGWVLADSWTLTLRGLSHWARNPTQILAGLAFPILMVLLFGGIFGSGMQVEGGGDYMDFLMPGMFVMSMAFGIGETMAGVTADASKGVTDRFRSMPMSAASVVIGQSIVNMLYSTVVLMILMGCGVIAGWSWNDGFMQALGAFALLLLLRFALLWVGIYLGLIIKTPEAASAVYTLLFPLGIVANTFASPEMMPGWLAAIAEWNPLSSTAHATRELFGNPGVGGTSWIAEHAMLMSFVWPLAIFAVFFPLAVRKYRALSR	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	101.85	gnl|BL_ORD_ID|4708|hsp_num:0	2518			6	801	tetracycline
BGC0001074.1|Cosmomycin_38 # 38059 # 38550 # 1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.711	BGC0001074.1|Cosmomycin_38 	38059	38550	+	Loose	500	24.2534	CPS-1	27.59	3003716	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CPS beta-lactamase	GTGCACGGCATGACCGTCTTCGACATCGCCATCGCGGACCTGAACGGCAAGCCCGACCTGCTGTCCCGCCACCGCGGCCGGACCCTGCTCATCGTCAACGTCGCCTCCCGCTGCGCCCTGGCCGGCCAGTACGCCGGGTTGGAGACACTCGCCCGCCGCCACCACGAGGACGGGCTCAGCGTCATCGGGGTGCCCTGCAACCAGTTCGGCGAGCAGGAACCGGGCACCCCCGAGGAGATCGCCGACTTCTGCGCCGTCCAGCAGATCACGTTCCCCCTCACCGAGAAGACCGACGTCAACGGAGCGGGCCGCCACCCCCTCTACGCCGCCCTGACGCCCTTCGCCGACGCGGAGGGCCACACCGGCGACGTGCGCTGGAACTTCGAGAAGTTCCTCGTCTCGTCCGCCGGCCACTGCGTGGGGCGCTTCGGCCCCACCGTCGAACCGCAGGACCCCGAACTCCTGCGCGCCGTCCGCGCGCAGGTGCAGTGA	MHGMTVFDIAIADLNGKPDLLSRHRGRTLLIVNVASRCALAGQYAGLETLARRHHEDGLSVIGVPCNQFGEQEPGTPEEIADFCAVQQITFPLTEKTDVNGAGRHPLYAALTPFADAEGHTGDVRWNFEKFLVSSAGHCVGRFGPTVEPQDPELLRAVRAQVQ	MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTDKGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYVDEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSCSFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVASHASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK	56.21	gnl|BL_ORD_ID|2028|hsp_num:0	2231			396	483	
BGC0001074.1|Cosmomycin_39 # 38604 # 40889 # 1 # ID=1_39;partial=00;start_type=GTG;rbs_motif=GAGGA;rbs_spacer=6bp;gc_cont=0.695	BGC0001074.1|Cosmomycin_39 	38604	40889	+	Loose	1280	51.9878	macB	32.65	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAACCAGACGCCGGTCACCGCAACCGACGAGGGCATTCAGGTCGTCGGTGCCCGAGAGAACAACCTGAGGGACGTCTCCCTCGTCATCCCCAAGAACCGCATCACCGTCTTCGTCGGCGTCTCCGGTTCCGGAAAGTCCTCCCTGGTCTTCGACACCGTCGCCGTGGAGGCCCAGCGGCAGCTCAACGCCACCTTCCCCTGGAACATCCGGCACGACCTGCCCAAGTTCGAACGGCCGCACGTCGACGCGGTCACCAGGCTCACCACCCCCGTGGTCGTCGACCAGCGGCCCCTCGGCGGCAACGCCCGCTCCACCGTCGGCACGGTCACCGACGTCTACACCGTGATGCGCGTGCTCTTCGCCAACCACGGCAACGACGGCCTCGGCCAGACCTGGCTCTACTCCTTCAACGACCCCAAGGGCATGTGCCCCGAGTGCGAGGGCCTCGGCCGCGCCCGGCGCGTCAGCCCCGAGCTGATGATCGACCGCGGGAAGTCGATCGCCGAGGGCGCCATCCTCCTCCCCGGCTACACCGTCGGCAGCGCGAACTGGCAGTTCTACGCCAACTACGAGCGCCTGGACGCCGAGAAGAAGCTCGCGGACTACACGGACGAGGAGATGCACACCCTGCTGCACGGCAGCAGCGGCACGGTCGAGGTGACCTACCCCAACGGCAACGTGCTGTCCCTGCGCTACGAGGGCCTCGTGGACAGCTTCGTCCGCCGCCACCTGAAGCGGGACACGGGCGGCATGAGCAAGGCCGCGCGCGACAAGGCGGCCGAGTTCTTCACCGAGGGCGTCTGCCCCACCTGCGAGGGCGCCCGGCTCAACCAGAAGGCACTCGCCACCCGCATCGACGGCCACAACATCGCCGACTGGTCCCAGATGCAGGTCAGCGACCTCATCGGCGTCGTCGCCACGCTGCGGGAGCGGCTCGACACGCCGCTCGTCACCACCATCATCGAGACCCTGGAGCAGATCCAGGCCATCGGCCTCGGCTACCTCACCCTGGACCGCTCCACCTCCACGCTCTCCGGCGGCGAGGGCCAGCGGCTCAAGCTCGTCAACCACCTCGGCAGCGAACTGACCGGGCTGACCTACATCTTCGACGAACCCAGCGTGGGCCTGCACCCCCGTGACGTCAGCCGGCTCAACGACCTGCTGCGCGCCCTGCGCGACAAGGGCAACACGGTCCTCGTCGTGGAGCACGACCCGGACGTCATGGCGGTCGCCGACCACGTCGTCGAGATCGGCCCCCGGGCGGGCGTCCACGGCGGCACCATCGTCTTCGAGGGCTCCCACGAGGAACTGCGCGCCGCGGACACACTGACCGGGCAGGGGCTGCGGCGCACCGGCGGGATCAAGGAGAACCCCCGCCCGTGGGGCCGCACCCTGCCGATCGTGAACGCGACGGCGAACAACCTGAAGAACGTCTCCACCGAGATCCCCACCGGCGTCCTGACCGCCGTCACCGGAGTGGCCGGCGCGGGCAAGAGCTCCCTGATCGCCCACGCCTTCCGCGCCCAGTACCCCGGGGCCGTGTTCGTCGACCAGTCGCCCATCCCGCGCTCCTCGCGGTCCACCCCGGCGAGCTACCTCAAGCTGATGGACCCGATCCGCAAGCTGTTCGCCAAGGCCAGCGGCGAGGACGCCAGCCTCTTCAGCTTCAACTCCAAGGGCGCCTGCGAGGAGTGCGAGGGGCGCGGCCTGCTCATCACCGAGGTCGCCTACATGGACCCGGTCACCACGCACTGCGAGGTCTGCGAGGGCCGCCGCTTCAAGGAGTCGGTGCTCCAGCACCGGGTGCGCGGCAAGAACATCGCGGACGTGCTGGAGATGTCCGCCGAGGAGGCGGGGGAGTTCTTCCTCTCGGGACCGCTGCGGGCCAAGGCCAACGCCCTGATCGAGACCGGCATCGGCTACCTCGGCCTCGGCCAGTCCCTGGCCACCCTGTCCGGCGGTGAGCGCCAGCGGCTCAAGCTCGCCGACCGGCTCTCCGGCTCGGGCACCGTCTACATCCTCGACGAGCCGACCACCGGCCTCCACCTGTCCGACATCGACAACCTCGTCGGCCTGCTCAACCGGATCGTCGACCGGGGCAACACCGTCATCGTCATCGAGCACGACCTGGCCGTGATCTCCCAGGCCGACTGGGTCATCGACCTCGGTCCGGAGGGCGGCAACACCGGCGGCGAGATCGTCTTCACGGGCACCCCGGCCGACCTGGCCCGGGCGGCGCACTCACACACCGGGCAGCACCTGAGCCTCTACCTGGCCCAGTAG	MNQTPVTATDEGIQVVGARENNLRDVSLVIPKNRITVFVGVSGSGKSSLVFDTVAVEAQRQLNATFPWNIRHDLPKFERPHVDAVTRLTTPVVVDQRPLGGNARSTVGTVTDVYTVMRVLFANHGNDGLGQTWLYSFNDPKGMCPECEGLGRARRVSPELMIDRGKSIAEGAILLPGYTVGSANWQFYANYERLDAEKKLADYTDEEMHTLLHGSSGTVEVTYPNGNVLSLRYEGLVDSFVRRHLKRDTGGMSKAARDKAAEFFTEGVCPTCEGARLNQKALATRIDGHNIADWSQMQVSDLIGVVATLRERLDTPLVTTIIETLEQIQAIGLGYLTLDRSTSTLSGGEGQRLKLVNHLGSELTGLTYIFDEPSVGLHPRDVSRLNDLLRALRDKGNTVLVVEHDPDVMAVADHVVEIGPRAGVHGGTIVFEGSHEELRAADTLTGQGLRRTGGIKENPRPWGRTLPIVNATANNLKNVSTEIPTGVLTAVTGVAGAGKSSLIAHAFRAQYPGAVFVDQSPIPRSSRSTPASYLKLMDPIRKLFAKASGEDASLFSFNSKGACEECEGRGLLITEVAYMDPVTTHCEVCEGRRFKESVLQHRVRGKNIADVLEMSAEEAGEFFLSGPLRAKANALIETGIGYLGLGQSLATLSGGERQRLKLADRLSGSGTVYILDEPTTGLHLSDIDNLVGLLNRIVDRGNTVIVIEHDLAVISQADWVIDLGPEGGNTGGEIVFTGTPADLARAAHSHTGQHLSLYLAQ	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	118.17	gnl|BL_ORD_ID|446|hsp_num:0	487			363	645	erythromycin
BGC0001074.1|Cosmomycin_40 # 41113 # 41943 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=5bp;gc_cont=0.748	BGC0001074.1|Cosmomycin_40 	41113	41943	+	Loose	700	24.6386	MOX-10	24.07	3003140	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGGACAAGGTCTGGCTGATCACGGGCGCGAGCAGTGGTTTCGGGCGGGCGATCGCCGAGGCCGCCCTCGCCGCGGGCGATGTCGTGGTGGGCGCGGCCCGCCGCCCCGAGGCGCTGGACGACCTGGTCGCCGCCCACCCCGGCCGGGTGGAGGCACTGCGCCTGGACGTCGCCGACACGGGCGCCGCCGCGGCCGCGGTACGGGACGTCGTGGCGCGGCACGGGCGGATCGACGTCCTGGTCAACAACGCGGGCCGGACGCACGTCGGGGCGTTGGAGGAGACCACCGAGGAGGAGTTGCGGGCGCTGTTCGAGGTGCATGTCTTCGGCCCGGCCGCCCTCACCCGGGCCGTGCTGCCGCACATGCGCGAGCGGCGCTCGGGCGCGATCGTGCAGATGAGCAGCATGGGCGGCCAGCTGTCCTTCGCGGGCTTCTCGGCGTACAGCGCCACGAAGTTCGCCCTGGAGGGCATGTCCGAGGGGCTCGCGGACGAGGTGGCCGAGTTCGGGATCAAGGTGCTGATCGTCGAGCCGGGCGCCTTCCGCACCGGCCTGTTCGAGACCGGGAGGGCCGGCGCCAGCCAGGACAGCGGCGTGTACGGCAAGGTGAGCGAGACCCGCGGCCTGGTCGCGGGCGGCGACGGCACCCAGCCGGGCGACCCGGCCAAGGCCGCGGCCCTGATCCTCGCCGCGCTGGAGGCCGACCCCACGCCCCTGCGCCTGCCGCTCGGCGACGACGGCGTCAGCGCGGTGCTCGGGCATCTGGACCGGGTGCGGGACGAGGTGCTGGCCTGGGAGAAGCGGAGCCGGAGCACGGGCTTCGACGACTGA	MDKVWLITGASSGFGRAIAEAALAAGDVVVGAARRPEALDDLVAAHPGRVEALRLDVADTGAAAAAVRDVVARHGRIDVLVNNAGRTHVGALEETTEEELRALFEVHVFGPAALTRAVLPHMRERRSGAIVQMSSMGGQLSFAGFSAYSATKFALEGMSEGLADEVAEFGIKVLIVEPGAFRTGLFETGRAGASQDSGVYGKVSETRGLVAGGDGTQPGDPAKAAALILAALEADPTPLRLPLGDDGVSAVLGHLDRVRDEVLAWEKRSRSTGFDD	MQQRQSFLWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWLKGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIGLFGHLAASSLKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGMLADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYPVSEQILLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLANRNYPIPARVKAAHAILTQLAR	72.25	gnl|BL_ORD_ID|3701|hsp_num:0	4771			846	1146	
BGC0001074.1|Cosmomycin_20 # 19036 # 19764 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=5bp;gc_cont=0.719	BGC0001074.1|Cosmomycin_20 	19036	19764	+	Loose	930	26.5646	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide	29.03	3004721	protein variant model	I351F	n/a	pyrazine antibiotic	antibiotic target alteration	pyrazinamide resistant rpsA	ATGTACAGCACGGACCTCGCCGAGGTCTACGAGACGGTGTACCGCAGCCGGGGCAAGGACTGGGCGGCGGAGGCCGAGGACATCGCGGCCCTGGCCCGCCGGCACGCCCCGGGCGCCGACGCGCTGCTCGACGTGGCGTGCGGCACCGCCGCCCATCTCGGCCCGTTCAGCAAGCTCTTCGCCACGGCGGAGGGCCTGGAGATCGCGGCGCCGATGCGCGACCTGGCGCTCGAGCGGTGGCCCGGCCTGACCATCCACGAGGGCGACATGCGCGACTTCGACCTCGGCCGCCGGTACTCCGTCGTCACCTGCATGTTCTGCGCCATCGGCTATCTGGGCAGCGTCGAGGAGATGCGCTCCGCCGTGGCCTCGATGGCCCGCCACCTCGAACCGGGAGGCGCGCTGATCATCGAACCCTGGTGGTTCCCGGAACAGTTCAAGGAGGGGTTCGTCGCCGGGGACCTGGCCCGCGAGGGCGACCGGACCGTGGCCCGGATCTCCCACTCCACCCTCCAGGGGCGCGCGACCCGGATGGAGGTCCGCTTCCTCGTCGGGGAGCCGTCGGGCATCCGGACCTTCACCGAGATCGACGTACTGACCCTCTTCACGCGTGACGAGTACGAGCAGGCGTTCCGGGACGCCGGCTGCTCCGTCGCGTACCGGCCGGGCCCGCCGACGGGCCGCGGTCTCTTCGTCGGAGTCAAGGAGCGGGAGGTGTCCGGGCGATGA	MYSTDLAEVYETVYRSRGKDWAAEAEDIAALARRHAPGADALLDVACGTAAHLGPFSKLFATAEGLEIAAPMRDLALERWPGLTIHEGDMRDFDLGRRYSVVTCMFCAIGYLGSVEEMRSAVASMARHLEPGGALIIEPWWFPEQFKEGFVAGDLAREGDRTVARISHSTLQGRATRMEVRFLVGEPSGIRTFTEIDVLTLFTRDEYEQAFRDAGCSVAYRPGPPTGRGLFVGVKEREVSGR	MPSPTVTSPQVAVNDIGSSEDFLAAIDKTIKYFNDGDIVEGTIVKVDRDEVLLDIGYKTEGVIPARELSIKHDVDPNEVVSVGDEVEALVLTKEDKEGRLILSKKRAQYERAWGTIEALKEKDEAVKGTVIEVVKGGLILDIGLRGFLPASLVEMRRVRDLQPYIGKEIEAKIIELDKNRNNVVLSRRAWLEQTQSEVRSEFLNNLQKGTIRKGVVSSIVNFGAFVDLGGVDGLVHVSELSWKHIDHPSEVVQVGDEVTVEVLDVDMDRERVSLSLKATQEDPWRHFARTHAIGQIVPGKVTKLVPFGAFVRVEEGIEGLVHISELAERHVEVPDQVVAVGDDAMVKVIDIDLERRRISLSLKQANEDYTEEFDPAKYGMADSYDEQGNYIFPEGFDAETNEWLEGFEKQRAEWEARYAEAERRHKMHTAQMEKFAAAEAAGRGADDQSSASSAPSEKTAGGSLASDAQLAALREKLAGSA	50.31	gnl|BL_ORD_ID|4709|hsp_num:0	3403			858	1188	pyrazinamide
BGC0001074.1|Cosmomycin_29 # 27706 # 28974 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.745	BGC0001074.1|Cosmomycin_29 	27706	28974	+	Loose	750	182.185	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	36.39	3003463	protein variant model	R121K, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCCGGCGGGTCGTGATCACCGGCATCGGGGTGGTGGCCCCCGGCGGCATCGGCACCAAGCAGTTCTGGGAGACCGTCACCGGCGGCCGCACCGCGACCCGGACCATCAGCCTGTTCGACCCCGCCCCGTTCCGCTCCCGGATCGCGGCCGAGTGCGACTTCGACGCCGCGGAGCAGGGCCTGAGCCCCGAGGACGCCGAACGGCTCGACCGGGCGGCGCAGTTCGCCCTGGTCGCGCTGCGCGAGGCCGTCACCGACAGCGGCTTGGAGCCCGACCCCGACACCGCCCACCGCACCGGCGTCAGCCTCGGCAGCGCGGTCGGCTGCACCCAGAAACTCGAAGAGGAGTACGTCGCCCTGAGCGGCGGCGGACAGGAGTGGCTCGTCGACCACACCGCCGCCGGCGCGCACCTCTACGACCACTTCGTGCCCAGCTCCATGGCCGCCGAACTCGCCTGGGAGGCCGGCGCCGAAGGCCCCTGCACCGTCGTCTCCGCCGGCTGCACCTCCGGCCTCGACTCGGTCGGGCACGCGGCCGCCCTCATCCGCGAGGGCACCGCCGACGTGATGATCGCCGGGGCCACCGACGCCCCCATCTCCCCGATCACCGTGGCCTGCTTCGACGCCATCCGCGCCACCTCGCCCCGCAACGACGACCCGGCGACCGCGCTGCGCCCCTTCGACCGCACCCGCAACGGCTTCGTCCTCGGCGAGGGCGCCGCCGTCCTGGTCCTGGAGGAGCTGACGGCGGCCCGGCGCCGGGGCGCCCACGTGTACGCCGAGATCGCCGGCTACGCCTCCCGGGGCAACGCGTACCACATGACCGGGCTGCGCACCGACGGACGCGAGCTCGCCGCCGCCGTCGACGCCGCCCTCGACGAGGCCCGGCTCGCCCCCGAGGCACTCGGGTACGTCAACGCCCACGGCACCGCCACCAAGCAGAACGACGTGCACGAGACGGCGGCCCTCAAGCGCAGCCTCGGATCCCACGCCCACCGCGTCCCGGTCAGCTCCATCAAGTCGATGATCGGGCACTCGCTCGGCGCCATCGGCTCCATCGAGGTCGCCGCCACCGCCCTGGCCCTCGAACACGGCGTCATCCCGCCCACCGCCAACCTGACCGACCCCGACCCCGACCTCGACCTGGACTACGTCCCCCTGCACGCCAGGGAGCGGACCATGTCGGCCGCGCTCACCGTGGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGGTGGTGCTGCGCCGGCCCGAGGGGCGGGCCGCATGA	MTRRVVITGIGVVAPGGIGTKQFWETVTGGRTATRTISLFDPAPFRSRIAAECDFDAAEQGLSPEDAERLDRAAQFALVALREAVTDSGLEPDPDTAHRTGVSLGSAVGCTQKLEEEYVALSGGGQEWLVDHTAAGAHLYDHFVPSSMAAELAWEAGAEGPCTVVSAGCTSGLDSVGHAAALIREGTADVMIAGATDAPISPITVACFDAIRATSPRNDDPATALRPFDRTRNGFVLGEGAAVLVLEELTAARRRGAHVYAEIAGYASRGNAYHMTGLRTDGRELAAAVDAALDEARLAPEALGYVNAHGTATKQNDVHETAALKRSLGSHAHRVPVSSIKSMIGHSLGAIGSIEVAATALALEHGVIPPTANLTDPDPDLDLDYVPLHARERTMSAALTVGSGFGGFQSAVVLRRPEGRAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			303	1245	isoniazid
